If any of the securities being registered on this Form are to be offered
on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. x
ABOUT
THIS PROSPECTUS
This prospectus describes
the general manner in which the Selling Stockholders may offer from time to time up to 12,240,000 Placement Shares held by Selling Stockholders,
consisting of (i) 700,000 Placement Shares; (ii) 3,300,000 Prefunded Warrant Shares; (iii) 4,000,000 Series A Preferred
Investment Option Shares; (iv) 4,000,000 Series B Preferred Investment Option Shares; and (v) 240,000 Wainwright Shares. You
should rely only on the information contained in this prospectus and the related exhibits, any prospectus supplement or amendment thereto
and the documents incorporated by reference, or to which we have referred you, before making your investment decision. Neither we nor
the Selling Stockholders have authorized anyone to provide you with different information. If anyone provides you with different or inconsistent
information, you should not rely on it. This prospectus, any prospectus supplement or amendments thereto do not constitute an offer to
sell, or a solicitation of an offer to purchase, the common stock offered by this prospectus, any prospectus supplement or amendments
thereto in any jurisdiction to or from any person to whom or from whom it is unlawful to make such offer or solicitation of an offer in
such jurisdiction. You should not assume that the information contained in this prospectus, any prospectus supplement or amendments thereto,
as well as information we have previously filed with the U.S. Securities and Exchange Commission (the “SEC”), is accurate
as of any date other than the date on the front cover of the applicable document.
If
necessary, the specific manner in which the shares of common stock may be offered and sold will be described in a supplement to this
prospectus, which supplement may also add, update or change any of the information contained in this prospectus. To the extent there
is a conflict between the information contained in this prospectus and any prospectus supplement, you should rely on the information
in such prospectus supplement, provided that if any statement in one of these documents is inconsistent with a statement in another document
having a later date — for example, a document incorporated by reference in this prospectus or any prospectus supplement —
the statement in the document having the later date modifies or supersedes the earlier statement.
Neither
the delivery of this prospectus nor any distribution of common stock pursuant to this prospectus shall, under any circumstances, create
any implication that there has been no change in the information set forth or incorporated by reference into this prospectus or in our
affairs since the date of this prospectus. Our business, financial condition, results of operations and prospects may have changed since
such date.
Unless
the context indicates otherwise, the terms “ToughBuilt,” “Company,” “we,” “us” and “our”
refer to ToughBuilt Industries, Inc., a Nevada corporation, and its subsidiaries.
PROSPECTUS
SUMMARY
This
summary provides a brief overview of the key aspects of our business and our securities. The reader should read the entire prospectus
carefully, especially the risks of investing in our securities discussed under “Risk Factors.” Some of the statements contained
in this prospectus, including statements under “Offering Summary” and “Risk Factors” as well as those noted in
the documents incorporated herein by reference, are forward-looking statements and may involve a number of risks and uncertainties. Our
actual results and future events may differ significantly based upon a number of factors. The reader should not put undue reliance on
the forward-looking statements in this document, which speak only as of the date on the cover of this prospectus.
Overview
We
were formed to design, manufacture, and distribute innovative tools and accessories to the building industry. We market and distribute
various home improvement and construction product lines for both Do-It-Yourself (“DIY”) and professional markets under
the TOUGHBUILT® brand name, within the global multibillion-dollar per year tool market. All of our products are designed by our in-house
design team. Since our initial launch of product sales eight years ago, we have experienced growth in annual sales from approximately
$1,000,000 in 2013 to approximately $70,000,000 in 2021.
Our
business is currently based on the development of innovative and state-of-the-art products, primarily in the tools and hardware
category, with a particular focus on the building and construction industry with the ultimate goal of making life easier and more
productive for contractors and workers alike. Our three major categories contain a total of 11 product lines, consisting of
(i) Soft Goods, which includes kneepads, tool bags, pouches, and toolbelts; (ii) Metal Goods, which consists of sawhorses,
tool stands, and workbench; and (iii) Utility Products, which includes utility knives, aviation snips, shears, lasers, and
levels. The Company also has several additional categories and product lines in various stages of development.
Our
mission consists, of providing products to the building and home improvement communities that are innovative, and of superior quality
derived in part from enlightened creativity for our end users while enhancing performance, improving well-being, and building high brand
loyalty.
We
operate through the following subsidiaries: (i) ToughBuilt Industries UK Limited; (ii) ToughBuilt Mexico; (iii) ToughBuilt
Amenia LLC; and (iv) ToughBuilt Brazil.
Business Developments
The
following highlights material business developments in our business during the fiscal year ended December 31, 2021 and during the first
quarter ended March 31, 2022:
| • | On
February 17, 2021, we announced that we have grown our business from four stock keeping units
(SKUs) to 25 SKUs with Toolstation, a Netherlands-based company with over 60 stores
in the Netherlands, Belgium and Luxembourg and one of the highly respected single-source
suppliers of tools, accessories, and building products for professionals and serious do-it-yourselfers.
These SKUs include current ranges of ToughBuilt’s steel sawhorse line, soft-sided tool
storage, and kneepads and have been slotted for immediate placement in all stores and Toolstation’s
catalog. |
| • | In
November 2021, we launched two new product lines, ToughBuilt lasers and levels, and fully
integrated with our mobile application, ToughBuilt Connect, allowing professional and DIY
builders to quickly measure rooms, seamlessly upload information to a smartphone, and create
shareable information with the touch of a button. |
|
• |
In December 2021, we launched a new product line, the ToughBuilt Workbench, available
for purchase across our strategic global partners and buying groups servicing over 14,400 stores worldwide. |
|
• |
In August 2021, we launched a new product line, the ToughBuilt utility knives. |
|
• |
In September 2021, we launched ToughBuilt Brazil. |
|
• |
In 2021, our total revenues, net of allowances, totaled
approximately $70.0 million as compared to approximately $39.4 million in 2020, including a 71% increase in online sales through
Amazon.com from $7 million in 2020 to $12 million in 2021. |
|
• |
Since the beginning of 2021, we have raised a total of approximately $119.5 million
in gross proceeds in registered and unregistered equity offerings and warrant exercises. |
Our Products
TOUGHBUILT®
manufactures and distributes an array of high-quality and rugged toolbelts, tool bags, and other personal tool organizer products. We
also manufacture and distribute a complete line of knee pads for various construction applications, and a variety of metal goods, including
utility knives, aviation snips, shears, and digital measures such as lasers and levels. Our line of job site tools and material support
products consists of a full line of miter saw and table saw stands, sawhorses/job site tables, roller stands, and workbench. All of our
products are designed and engineered in the United States and manufactured in China, India, and the Philippines under our quality control
supervision. We do not need government approval for any of our products.
Soft Goods
The
flagship of the product line is the soft goods line that consists of over 100 variations of tool pouches, tool rigs, toolbelts and accessories,
tool bags, totes, a variety of storage solutions, and office organizers/bags for laptop/tablet/cellphones, etc. Management believes that
the breadth of the line is one of the deepest in the industry and has specialized designs to suit professionals from all sectors of the
industry including plumbers, electricians, framers, builders, and more.
We
have a selection of over 10 models of kneepads, some with unique patented design features that allow the users to interchange components
to suit particular conditions of use. Management believes that these kneepads are among the best performing kneepads in the industry.
Our “all terrain” knee pad protection with snapshell technology is part of our interchangeable kneepad system which helps
to customize the job site needs. They are made with superior quality using multilevel layered construction, heavy-duty webbing, and abrasion-resistant
PVC rubber.
Metal Goods
Sawhorses
and Work Support Products
The
second major category consists of Sawhorses and Work Support products with unique designs targeted at the most discerning users in the
industry. The innovative designs and construction of the more than 15 products in this category have led to the sawhorses becoming among
the best sellers of the category everywhere they are sold. The newest additions in this category include several stands and work support
products that are quickly gaining recognition in the industry and are expected to position themselves in the top tier products in a short
time. Our sawhorse line, miter saw, table saw & roller stands and workbench are built to very high standards. Our sawhorse/job site
table is fast to set up, holds 2,400 pounds, has adjustable heights, is made of all-metal construction, and has a compact design. We
believe that these lines of products will become the standard in the construction industry.
Our Business
Strategy
Our
product strategy is to develop product lines in a number of categories rather than focus on a single line of goods. We believe that this
approach allows for rapid growth, and wider brand recognition, and may ultimately result in increased sales and profits within an accelerated
time period. We believe that building brand awareness of our current ToughBuilt lines of products will expand our share of the pertinent
markets. Our business strategy includes the following key elements:
|
• |
A commitment to technological innovation achieved through
consumer insight, creativity, and speed to market; |
|
• |
A broad selection of products in both brand and private
labels; |
|
• |
Prompt response; |
|
• |
Superior customer service; and |
|
• |
Value pricing. |
We
will continue to consider other market opportunities while focusing on our customers’ specific requirements to increase sales.
Market
In
addition to the construction market, our products are marketed to the “Do-It-Yourself” and home improvement marketplace.
The U.S. housing stock of more than 130 million homes requires regular investment merely to offset normal depreciation. According to
Statista.com1, in recent years, the U.S. home improvement industry has witnessed steady growth, and the trend is expected
to continue in the near future. A significant increase occurred in 2020, mostly due to the outbreak of the coronavirus (COVID-19) pandemic
and the lockdowns which ensued, leading people to stay home more often than before and take up hobbies and projects such as DIY home
improvement. According to a Joint Center for Housing Studies forecast, homeowner improvements and repair expenditures were expected to
reach roughly 370 billion U.S. dollars in the first quarter of 2022. Aside from the pandemic2, the rising real estate prices
in many Western countries were a likely contributing factor to the increase in home improvement projects. With real estate price changes
outperforming wage increases, homeowners may have opted for upgrading their homes instead of purchasing a new house.
TOUGHBUILT®
products are available worldwide in many major retailers ranging from home improvement and construction products and services stores
to major online outlets. Currently, we have placements in Lowes, Home Depot, Menards, Bunnings (Australia), Princess Auto (Canada), Dong
Shin Tool PIA (S. Korea) as well as seeking to grow our sales in global markets such as Western and Central Europe, Eastern Europe,
South America, and the Middle East.
Retailers
by region include:
|
• |
United States: Lowe’s, Home Depot,
Menards, GM products, Fire Safety, Hartville Hardware, ORR, Pooley, Wesco, Buzzi, and Western Pacific Building Materials. |
|
• |
Canada: Princess Auto. |
|
• |
United Kingdom distribution throughout the UK and online
selling for Europe. |
|
• |
Australia: Kincrome, and Bunnings. |
|
• |
New Zealand: Kincrome, and Bunnings. |
|
• |
Russia: VSEInstrumenti.ru. |
|
• |
South Korea: Dong Shin Tool PIA Co., Ltd. |
We
are actively expanding into markets in Mexico and other Latin American countries, the Middle East, and South Africa.
We
are currently in product line reviews and discussions with Home Depot Canada, Do It Best, True Value, and other major retailers both
domestically and internationally. A product line review requires the supplier to submit a comprehensive proposal that includes product
offerings, prices, competitive market studies, relevant industry trends, and other information. Management anticipates, within the near
term, adding to its customer base up to three major retailers, along with several distributors and private retailers within six sectors
and among fifty-six targeted countries.
| 1 | “Home
Depot and Lowe’s: average amount spent by consumers 2011-2021”; published by
C. Simionato (April 26, 2022); https://www.statista.com/statistics/240861/average-amount-spent-by-consumers-at-the-home-depot-and-lowes/ |
| 2 | “Home
improvement projects - statistics & facts”; published by C. Simionato; (Jan 12,
2022); https://www.statista.com/topics/7899/home-improvement-projects/#topicHeader__wrapper |
New Products
Tools
In
2021, we launched the following product lines:
|
• |
Lasers; |
|
• |
Levels; |
|
• |
Utility knives; and |
|
• |
Workbench. |
Mobile
Device Products
Since
2013, we have been planning, designing, engineering, and sourcing the development of a new line of ToughBuilt mobile devices and accessories
to be used in the construction industry and by building enthusiasts. We are planning to have our mobile device products ready to market
in 2024 at which time we intend to commence marketing and selling our mobile device products to our current global customer base. We
believe that an increasing number of companies in the construction industry are requiring their employees to utilize mobile devices not
just to communicate with others but to utilize special apps that will allow the construction workers to do their job better and more
efficiently. All of our mobile devices are designed and built in accordance with IP-68 and to a military standard level of durability.
Our
ruggedized mobile line of products was created to place customized technology and a wide variety of data in the palm of building professionals
and enthusiasts such as contractors, subcontractors, foremen, general laborers, and others. We are designing the devices, accessories,
and custom apps to allow the users to plan with confidence, organize faster, find labor and products faster, estimate accurately, purchase
wisely, protect themselves, workers, and their business, create and track invoicing faster and easier.
Commencing
in 2024, we intend to launch the following accessories: car charger, QI charger, car mounts, and earbud pack, and we will focus on sales
in the following industries: construction, industrial, military, and law enforcement and “dotcoms.” In late 2024, we intend
to launch our T.55 rugged mobile phones and earbud headphones, as well as a “T-Dock,” attachable battery, tri lens camera,
and tough shield cover and accessories.
In
late 2024, we also intend to launch applications for our mobile phones relating to the following topics:
|
1. |
National building codes |
|
2. |
Inspection booking |
|
3. |
Labor ready |
|
4. |
Estimating apps & programs |
|
5. |
Structural engineers |
|
6. |
Architects |
|
7. |
Building plans |
|
8. |
Workers comp |
|
9. |
Equipment insurance |
|
10. |
Project insurance & bonds |
|
11. |
Vehicle insurance |
|
12. |
Liability insurance |
|
13. |
Umbrella insurance |
|
14. |
Collection agencies |
|
15. |
Construction loans |
|
16. |
Small business loans |
|
17. |
Job listings |
|
18. |
Tool exchange |
Intellectual
Property
We
hold several patents and trademarks of various durations and believe that we hold or have applied for, or license all of the patent,
trademark, and other intellectual property rights necessary to conduct our business. We utilize trademarks (licensed and owned) on
nearly all of our products and believe having distinctive marks that are readily identifiable is an important factor in creating a market
for our goods, in identifying our brands and our Company, and in distinguishing our goods from the goods of others. We consider our ToughBuilt®,
Cliptech®, and Fearless® trademarks to be among our most valuable intangible assets. Trademarks registered
both in and outside the U.S. are generally valid for 10 years, depending on the jurisdiction, and are generally subject to an indefinite
number of renewals for a like period on the appropriate application.
In
2019, the United States Patent and Trademark Office (USPTO) granted two new design patents (U.S. D840,961 S and US D841,635 S) that
cover ToughBuilt’s ruggedized mobile devices, which are valid for 15 years. We also have several patents pending with the USPTO
and anticipate three or four of them to be granted in the near future.
Implications
of Being an Emerging Growth Company and a Smaller Reporting Company
We
are an “emerging growth company,” as defined in the JOBS Act. We will remain an emerging growth company until the
earlier of (i) the last day of the fiscal year following the fifth anniversary of the date of the first sale of our common stock
pursuant to an effective registration statement under the Securities Act; (ii) the last day of the fiscal year in which we have
total annual gross revenues of $1.07 billion or more; (iii) the date on which we have issued more than $1 billion in nonconvertible
debt during the previous three years; or (iv) the date on which we are deemed to be a large accelerated filer under applicable SEC
rules. We expect that we will remain an emerging growth company for the foreseeable future but cannot retain our emerging growth company
status indefinitely and will no longer qualify as an emerging growth company on or before the last day of the fiscal year following the
fifth anniversary of the date of the first sale of our common stock pursuant to an effective registration statement under the Securities
Act. For so long as we remain an emerging growth company, we are permitted and intend to rely on exemptions from specified disclosure
requirements that are applicable to other public companies that are not emerging growth companies. These exemptions include:
|
• |
being permitted to provide only two years of audited financial statements, in addition
to any required unaudited interim financial statements, with correspondingly reduced “Management’s Discussion and Analysis
of Financial Condition and Results of Operations” disclosure; |
|
• |
not being required to comply with the requirement of auditor attestation of our internal
controls over financial reporting; |
|
• |
not being required to comply with any requirement that may be adopted by the Public
Company Accounting Oversight Board regarding mandatory audit firm rotation or a supplement to the auditor’s report providing
additional information about the audit and the financial statements; |
|
• |
reduced disclosure obligations regarding executive compensation; and |
|
• |
not being required to hold a nonbinding advisory vote on executive compensation and
stockholder approval of any golden parachute payments not previously approved. |
An
emerging growth company can take advantage of the extended transition period provided in Section 7(a)(2)(B) of the Securities Act
for complying with new or revised accounting standards. This allows an emerging growth company to delay the adoption of certain accounting
standards until those standards would otherwise apply to private companies. We have irrevocably elected to avail ourselves of this extended
transition period and, as a result, we will not be required to adopt new or revised accounting standards on the dates on which adoption
of such standards is required for other public reporting companies.
We
are also a “smaller reporting company” as defined in Rule 12b-2 of the Exchange Act and have elected to take advantage of
certain of the scaled disclosure available for smaller reporting companies. We will remain a smaller reporting company until the end
of the fiscal year in which (i) we have a public common equity float of more than $250 million, or (ii) we have annual revenues
for the most recently completed fiscal year of more than $100 million and a public common equity float or a public float of more than
$700 million. We also would not be eligible for status as a smaller reporting company if we become an investment company, an asset-backed
issuer or a majority-owned subsidiary of a parent company that is not a smaller reporting company.
We
have elected to take advantage of certain of the reduced disclosure obligations in the registration statement of which this prospectus
is a part and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that
we provide to our stockholders may be different from what you might receive from other public reporting companies in which you hold equity
interests.
Recent Developments
July 2022 Private Placement of Common Stock and Warrants
On
July 27, 2022, we consummated the closing of the Private Placement, pursuant to the terms and conditions of the Securities Purchase Agreement,
dated as of July 25, 2022 (the “Purchase Agreement”), by and among the Company and certain institutional investors named
on the signature pages thereto (the “Purchasers”). At the closing of the Private Placement, the Company issued (i) 700,000
Placement Shares, (ii) 3,300,000 Prefunded Warrants; (iii) 4,000,000 Series A Preferred Investment Options; and (iv) 4,000,000
Series B Preferred Investment Options. The purchase price of each Placement Share and associated Preferred Investment Options was $5.00
and the purchase price of each Prefunded Warrant and associated Preferred Investment Options was $4.9999.
Each
Prefunded Warrant is exercisable for $0.0001 per share of common stock until all of the Prefunded Warrants are exercised in full. Each
Series A Preferred Investment Option is exercisable for one share of common stock for $5.00 per share until the third anniversary date
of the issuance date. Each Series B Preferred Investment Option is exercisable for one share of common stock for $5.00 per share until
the second anniversary date of the issuance date. The exercise price and the number of our shares of common stock issuable upon the exercise
of each of the Warrants are subject to adjustment for stock splits, reverse splits, and similar capital transactions, as described in
the Warrants. The Preferred Warrants are exercisable on a “cashless” basis. The Preferred Investment Options may be exercised
on a “cashless basis” if there is no effective registration for the underlying shares of common stock.
A holder of the Warrants
will not have the right to exercise any portion of the Prefunded Warrants, Series A Preferred Investment Options or Series B Preferred
Investment Options, as the case may be if the holder (together with its affiliates) would beneficially own more than 4.99% or 9.99%
of the number of shares of common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined
in accordance with the terms of the Warrants. However, upon notice from the holder to the Company, the holder may increase the beneficial
ownership limitation, which may not exceed 9.99% of the number of shares of common stock outstanding immediately after giving effect to
the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants, provided that any increase in the
beneficial ownership limitation will not take effect until 61 days following notice to the Company.
The
net proceeds to the Company from the Private Placement were approximately $18.4 million, after deducting placement agent fees and other
offering expenses to H.C. Wainwright & Co., LLC, (“Wainwright”) acted as the exclusive placement agent for the
Private Placement. In consideration for acting as the placement agent of the offering, Wainwright received a cash fee equal to 7.0% of
the aggregate gross proceeds of the offering and warrants (the “Wainwright Warrants”) to purchase up to 240,000 shares
of our common stock, which is equivalent to 6.0% of the Placement Shares and Prefunded Warrants sold in the Private Placement for $6.25
per share until July 28, 2025. We also agreed to pay Wainwright a management fee equal to 0.5% of the aggregate gross proceeds from the
offering, a $25,000 non-accountable expense and reimburse certain out-of-pocket expenses up to an aggregate of $100,000. In addition,
upon any exercise for cash of any of the Preferred Investment Options, we agreed to pay Wainwright a cash fee of 7.0% of the aggregate
gross exercise price paid in cash and a management fee of 0.5% of the aggregate gross exercise price paid in cash and to issue to Wainwright
warrants to purchase the number of shares equal to 6.0% of the aggregate number of Placement Shares underlying the Preferred Investment
Options that have been exercised.
For a description of the
Warrants, please see the section titled “July 2022 Private Placement of Common Stock and Warrants” under “Description
of Capital Stock” of this prospectus.
June 2022 Public Offering of Units and
Prefunded Units
On
June 22, 2022, we completed a public offering of (i) 772,157 units (“Units”), each Unit consisting of one share of common
stock and one warrant to purchase one share of common stock (each, a “Warrant”) for $1.90 per Unit; and (ii) 2,385,738
prefunded units (“Prefunded Units”), each Prefunded Unit consisting of one prefunded warrant (a “Prefunded Warrant”) to
purchase one share of common stock and one Warrant, for $1.8999 per Prefunded Unit. Subject to certain ownership limitations described
in the Warrants, the Warrants have an exercise price of $1.90 per share of common stock, are exercisable upon issuance and will expire
five years from the date of issuance. The exercise price of the Warrants is subject to adjustment for stock splits, reverse splits, and
similar capital transactions as described in the warrants. In connection with the offering, the Company issued Warrants to purchase an
aggregate of 3,157,895 shares of common stock. Subject to certain ownership limitations described in the Prefunded Warrants, the Prefunded
Warrants are immediately exercisable and may be exercised at a nominal consideration of $0.0001 per share of common stock any time until
all of the Prefunded Warrants are exercised in full. We received net proceeds of approximately $5.1 million from the offering, after
deducting the estimated offering expenses payable by the Company, including the placement agent fees. Wainwright acted as the exclusive
placement agent for the Private Placement. See the section titled “June 2022 Public Offering of Units and Prefunded Units” under “Description of Capital Stock”
of this prospectus for more information.
Implications
of Being an Emerging Growth Company and a Smaller Reporting Company
We
qualify as an “emerging growth company,” as defined in the JOBS Act. For as long as we remain an emerging growth company,
we may take advantage of certain exemptions from various reporting requirements that are applicable to other public companies. These
provisions include, but are not limited to:
| · | being
permitted to have only two years of audited financial statements and only two years of related
selected financial data and management’s discussion and analysis of financial condition
and results of operations disclosure; |
| · | an
exemption from compliance with the auditor attestation requirement in the assessment of our
internal control over financial reporting pursuant to Section 404 of the Sarbanes-Oxley Act
of 2002, as amended, or the Sarbanes-Oxley Act; |
| · | reduced
disclosure about executive compensation arrangements in our periodic reports, registration
statements and proxy statements; and |
| · | exemptions
from the requirements to seek non-binding advisory votes on executive compensation or golden
parachute arrangements. |
In
addition, the JOBS Act permits emerging growth companies to take advantage of an extended transition period to comply with new or revised
accounting standards applicable to public companies. We are not choosing to “opt out” of this provision. We will remain an
emerging growth company until the earliest of (i) the last day of the fiscal year following the fifth anniversary of the completion
of our IPO, (ii) the last day of the first fiscal year in which our annual gross revenues exceed $1.07 billion, (iii) the date
on which we have, during the immediately preceding three-year period, issued more than $1.0 billion in non-convertible debt securities
and (iv) the end of any fiscal year in which the market value of our common stock held by non-affiliates exceeds $700 million as
of the end of the second quarter of that fiscal year. We have elected to take advantage of certain of the reduced disclosure obligations
in the registration statement of which this prospectus forms a part and may elect to take advantage of other reduced reporting requirements
in future filings. As a result, the information that we provide to our stockholders may be different than you might receive from other
public reporting companies in which you hold equity interests.
We
are also a “smaller reporting company” as defined in the Securities Exchange Act of 1934, as amended, or the Exchange Act.
We may continue to be a smaller reporting company even after we are no longer an emerging growth company. We may take advantage of certain
of the scaled disclosures available to smaller reporting companies and will be able to take advantage of these scaled disclosures for
so long as the market value of our voting and non-voting common stock held by non-affiliates is less than $250 million measured on the
last business day of our second fiscal quarter, or our annual revenue is less than $100 million during the most recently completed fiscal
year and the market value of our voting and non-voting common stock held by non-affiliates is more than $700 million measured on the
last business day of our second fiscal quarter.
Summary
of Risk Factors
Our
business is subject to a number of risks. You should be aware of these risks before making an investment decision. These risks are discussed
more fully in the section titled “Risk Factors” included those set forth under “Risk Factors” starting on page
13 of this prospectus and other risk factors discussed under Item 1A. Risk Factors of our 2021 Form 10-K filed with the SEC on April
18, 2022 and incorporated by reference herein.
Risks
include, but are not limited to, the following:
|
• |
We will require additional capital in order to achieve
commercial success and, if necessary, to finance future losses from operations as we endeavor to build revenue, but we do not have
any commitments to obtain such capital and we cannot assure you that we will be able to obtain adequate capital as and when required; |
|
• |
If the hosts of third-party marketplaces limit our access
to such marketplaces, our operations and financial results will be adversely affected; |
|
• |
We are highly dependent upon manufacturers in China,
India, and the Philippines and an interruption in such relationships or our ability to obtain products from them could adversely
affect our business and results of operations; |
|
• |
Our financial condition and results of operations for
the fiscal year 2022 may be adversely affected by the coronavirus outbreak; |
|
• |
The increase in commodity prices such as fuel, plastic,
and metal could negatively impact our profit margins; |
|
• |
The Company’s results of operations could be negatively
impacted by inflationary or deflationary economic conditions which could affect the ability to obtain goods from our suppliers in
a timely and cost-effective manner; |
|
• |
Product liability claims and other kinds of litigation
could affect our business, reputation, financial condition, results of operations, and cash flows; |
|
• |
Failure to comply with privacy laws and regulations and
failure to adequately protect customer data could harm our business, damage our reputation and result in a loss of customers; |
|
• |
If we are unable to protect our intellectual property
rights, our reputation and brand could be impaired, and we could lose customers; |
|
• |
Existing or future government regulation could expose
us to liabilities and costly changes in our business operations and could reduce customer demand for our products and services; |
|
• |
Geopolitical conditions, including trade disputes and
direct or indirect acts of war or terrorism, could have an adverse effect on our operations and financial results; |
|
• |
Our shares will be subject to potential delisting if
we do not maintain the listing requirements of the Nasdaq Capital Market, including the $1.00 minimum closing bid requirement; |
|
• |
As an “emerging growth company” and a “smaller
reporting company” under applicable law, we will be subject to lessened disclosure requirements, which could leave our stockholders
without information or rights available to stockholders of more mature companies; |
|
• |
If research analysts do not publish research about our
business or if they issue unfavorable commentary or downgrade our common stock, our stock price and trading volume could decline; |
|
• |
We do not currently intend to pay dividends on our common
stock in the foreseeable future, and consequently, your ability to achieve a return on your investment will depend on an appreciation
in the price of our common stock; and |
|
• |
The security of our information technology systems may
be compromised in the event of system failures, unauthorized access, cyberattacks, or a deficiency in our cybersecurity, and confidential
information, including non-public personal information that we maintain, could be improperly disclosed. |
Corporate History
We
were incorporated in the State of Nevada on April 9, 2012. Our principal executive offices are located at 8669 Research Drive, Irvine,
CA 92618, and our telephone number is (949) 528-3100. Our corporate website is www.toughbuilt.com. The information contained on
or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an
inactive textual reference only.
OFFERING
SUMMARY
|
Common stock outstanding before this offering: |
|
8,980,531 shares |
|
|
|
|
|
|
|
Common stock outstanding after completion of this offering: |
|
20,520,531 shares (assuming full exercise of the Warrants that are exercisable for
the Warrant Shares offered hereby). However, we will receive gross proceeds of approximately $41.5 million if all of the Warrants
held by the Selling Stockholders are exercised for cash, excluding fees payable to Wainwright and other expenses. We intend to use
any of the net proceeds from Warrant exercises for working capital purposes. |
|
|
|
|
|
|
|
Use of Proceeds: |
|
We will not receive any proceeds from the sale of the common stock by the Selling
Stockholders. |
|
|
|
|
|
|
|
Transfer Agent: |
|
Vstock Transfer, LLC |
|
|
|
|
|
|
|
Nasdaq Capital Market Symbol: |
|
Our shares of common stock are listed on the Nasdaq Capital Market under the symbol
“TBLT.” |
|
|
|
|
|
|
|
Dividend Policy: |
|
We have never declared or paid any cash dividends on our shares of common stock.
We do not anticipate paying any cash dividends in the foreseeable future. |
|
|
|
|
|
|
|
Risk Factors: |
|
An investment in our common stock involves a high degree of risk. You should read
this prospectus carefully, including the section titled “Risk Factors” and the combined and condensed consolidated financial
statements and the related notes to those statements included in this prospectus, before investing in our common stock |
|
Assumptions Used
Throughout this Prospectus
Excludes
the following other securities as of August 3, 2022:
|
• |
8,334 shares of common stock issuable upon the conversion
of 250 shares of Series F Convertible Preferred Stock; |
|
• |
8,334 shares of common stock issuable upon the conversion
of 250 shares of Series G Convertible Preferred Stock; |
|
• |
8,893,473 shares of common stock issuable as of the date
hereof upon the exercise of common stock outstanding warrants with a weighted average exercise price of $12.48 per share; |
|
• |
83 shares of common stock available for future issuance
under the Company 2016 Equity Incentive Plan; |
|
• |
625 shares of common stock available for future issuance
under the Company 2018 Equity Incentive Plan; and |
|
• |
1,354 shares of common stock issuable upon the exercise
of outstanding stock options and RSUs. |
Except
as otherwise noted, all information in this prospectus reflects and assumes no exercise of the Warrants.
SUMMARY
FINANCIAL DATA
The
following tables summarize our financial data. We derived the summary financial statement data for the three months ended March 31, 2022
and 2021 and for the fiscal years ended December 31, 2021 and 2020 set forth below from our audited financial statements and related
notes contained in this prospectus. Our historical results are not necessarily indicative of the results that may be expected in the
future. You should read the information presented below together with “Management’s Discussion and Analysis of Financial
Condition and Results of Operations,” our financial statements, the notes to those statements and the other financial information
contained in this prospectus.
Summary of Operations
in U.S. Dollars
|
|
Three Months
Ended
March 31, |
|
|
Fiscal
Year Ended
December 31, |
|
|
|
2022
(unaudited) |
|
|
2021
(unaudited) |
|
|
2021
(audited) |
|
|
2020
(audited) |
|
Net Revenue |
|
$ |
17,220,744 |
|
|
$ |
12,282,255 |
|
|
$ |
70,026,324 |
|
|
$ |
39,433,617 |
|
Cost of Goods Sold |
|
|
14,217,617 |
|
|
|
8,819,127 |
|
|
|
50,912,513 |
|
|
|
26,722,722 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OPERATING EXPENSES |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Selling, general and administrative |
|
|
(15,934,045 |
) |
|
|
(7,949,783 |
) |
|
|
(51,434,180 |
) |
|
|
(22,191,041 |
) |
Research and development |
|
|
(2,514,050 |
) |
|
|
(1,406,385 |
) |
|
|
(6,980,453 |
) |
|
|
(5,056,811 |
) |
Operating loss |
|
|
(18,448,095 |
) |
|
|
(9,356,168 |
) |
|
|
(39,300,822 |
) |
|
|
(14,386,957 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
OTHER INCOME (LOSS) |
|
|
(3,341,030 |
) |
|
|
(160,619 |
) |
|
|
(1,774,924 |
) |
|
|
(2,961,665 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
NET LOSS |
|
|
(12,103,938 |
) |
|
|
(6,053,659 |
) |
|
|
(37,525,898 |
) |
|
|
(17,348,622 |
) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss per common share (basic and diluted) |
|
$ |
(14.04 |
) |
|
$ |
(13.43 |
) |
|
$ |
(0.37 |
) |
|
$ |
(0.68 |
) |
Balance Sheet in
U.S. Dollars
|
|
As of March
31, |
|
|
As of December
31, |
|
|
|
2022 |
|
|
2021 |
|
|
2021 |
|
|
2020 |
|
|
|
Actual
(unaudited) |
|
|
Actual
(unaudited) |
|
|
Actual
(audited) |
|
|
Actual
(audited) |
|
Cash |
|
$ |
936,822 |
|
|
$ |
32,497,932 |
|
|
$ |
7,472,224 |
|
|
$ |
2,194,850 |
|
Total Current Assets |
|
|
58,414,011 |
|
|
|
60,836,909 |
|
|
|
64,870,205 |
|
|
|
24,296,037 |
|
Total Assets |
|
|
77,464,843 |
|
|
|
65,362,726 |
|
|
|
78,954,525 |
|
|
|
27,490,694 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Current Liabilities |
|
|
28,279,810 |
|
|
|
7,316,865 |
|
|
|
21,058,002 |
|
|
|
8,144,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Liabilities |
|
|
29,727,852 |
|
|
|
7,316,865 |
|
|
|
21,058,002 |
|
|
|
8,144,641 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Additional paid-in capital |
|
|
158,031,423 |
|
|
|
124,853,351 |
|
|
|
156,171,483 |
|
|
|
80,103,653 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Total Stockholders Equity |
|
$ |
47,736,991 |
|
|
$ |
65,362,726 |
|
|
$ |
57,896,523 |
|
|
$ |
19,346,053 |
|
CAUTIONARY
STATEMENT REGARDING FORWARD-LOOKING STATEMENTS
This
prospectus contains forward-looking statements that involve substantial risks and uncertainties. The forward-looking statements are contained
principally in the sections titled “Prospectus Summary,” “Risk Factors,” “Management’s Discussion
and Analysis of Financial Condition and Results of Operations” and “Business,” but are also contained elsewhere in
this prospectus. In some cases, you can identify forward-looking statements by the words “may,” “might,” “will,”
“could,” “would,” “should,” “expect,” “intend,” “plan,” “objective,”
“anticipate,” “believe,” “estimate,” “predict,” “project,” “potential,”
“continue” and “ongoing,” or the negative of these terms, or other comparable terminology intended to identify
statements about the future, although not all forward-looking statements contain these words. These statements relate to future events
or our future financial performance or condition and involve known and unknown risks, uncertainties and other factors that could cause
our actual results, levels of activity, performance or achievement to differ materially from those expressed or implied by these forward-looking
statements. These forward-looking statements include, but are not limited to, statements about:
| · | the
impact of the worldwide COVID-19 pandemic and government actions, on our business; |
| · | supply
chain disruptions; |
| · | our
limited operating history; |
| · | our
ability to manufacture, market and sell our products; |
| · | our
ability to maintain or protect the validity of our U.S. and other patents and other intellectual
property; |
| · | our
ability to launch and penetrate markets; |
| · | our
ability to retain key executive members; |
| · | our
ability to internally develop new inventions and intellectual property; |
| · | interpretations
of current laws and the passages of future laws; and |
| · | acceptance
of our business model by investors. |
The
foregoing does not represent an exhaustive list of matters that may be covered by the forward-looking statements contained herein or
risk factors that we are faced with that may cause our actual results to differ from those anticipated in our forward-looking statements.
These
forward-looking statements are subject to a number of risks, uncertainties and assumptions, including those described in “Risk
Factors.” It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business
or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any
forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances
discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied
in the forward-looking statements.
You
should not rely upon forward-looking statements as predictions of future events. Although we believe that the expectations reflected
in the forward-looking statements are reasonable, we cannot guarantee that the future results, levels of activity, performance or events
and circumstances reflected in the forward-looking statements will be achieved or occur. Moreover, except as required by law, neither
we nor any other person assumes responsibility for the accuracy and completeness of the forward-looking statements. We undertake no obligation
to update publicly any forward-looking statements for any reason after the date of this prospectus to conform these statements to actual
results or to changes in our expectations.
You
should read this prospectus and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the registration
statement of which this prospectus forms a part with the understanding that our actual future results, levels of activity, performance
and events and circumstances may be materially different from what we expect.
MARKET DATA
Market
data and certain industry data and forecasts used throughout this prospectus were obtained from internal company surveys, market research,
consultant surveys, publicly available information, reports of governmental agencies and industry publications and surveys. Industry
surveys, publications, consultant surveys and forecasts generally state that the information contained therein has been obtained from
sources believed to be reliable, but the accuracy and completeness of such information are not guaranteed. To our knowledge, certain
third-party industry data that includes projections for future periods does not take into account the effects of the worldwide coronavirus
pandemic. Accordingly, those third-party projections may be overstated and should not be given undue weight. Forecasts are particularly
likely to be inaccurate, especially over long periods of time. In addition, we do not necessarily know what assumptions regarding general
economic growth were used in preparing the forecasts we cite. Statements as to our market position are based on the most currently available
data. While we are not aware of any misstatements regarding the industry data presented in this prospectus, our estimates involve risks
and uncertainties and are subject to change based on various factors, including those discussed under the heading “Risk Factors”
in this prospectus.
TRADEMARKS
Solely
for convenience, our trademarks and tradenames referred to in this prospectus may appear without the ® or ™ symbols, but such
references are not intended to indicate in any way that we will not assert, to the fullest extent under applicable law, our rights to
these trademarks and tradenames. All other trademarks, service marks, and trade names included or incorporated by reference into this
prospectus or the accompanying prospectus are the property of their respective owners.
RISK
FACTORS
The
following is only a summary of the risks pertaining to our Company. Investment in our securities involves risks. You should
carefully consider the following risk factors in addition to other information contained in this prospectus as well as in our Form
10-K for the fiscal year ended December 31, 2021, and other materials filed with the SEC and incorporated by reference herein. The
occurrence of any of the following risks might cause you to lose all or part of your investment. Some statements in this prospectus,
including statements in the following risk factors, constitute “forward-looking
statements.” See “Incorporation of Certain Information by Reference” in this prospectus.
Risks Related
to Our Company
We will
require additional capital in order to achieve commercial success and, if necessary, to finance future losses from operations as we endeavor
to build revenue, but we do not have any commitments to obtain such capital and we cannot assure you that we will be able to obtain adequate
capital as and when required.
We
may not be able to generate any profit in the foreseeable future. For the year ended December 31, 2021, we have a net loss of $37,525,898,
compared to a net loss of $17,348,622 for the year ended December 31, 2020. For the quarter ended March 31, 2022, we have a net loss
of $12,103,938, compared to a net loss of $6,053,659 for the quarter ended March 31, 2021. Accordingly, there is no assurance that we
will realize profits in the remainder of fiscal 2022 or thereafter. If we fail to generate profits from our operations, we will not be
able to sustain our business. We may never report profitable operations or generate sufficient revenue to maintain our Company as a going
concern. We continue to control our cash expenses as a percentage of expected revenue on an annual basis and thus may use our cash balances
in the short term to invest in revenue growth; however, we cannot give assurance that we can increase our cash balances or limit our
cash consumption and thus maintain sufficient cash balances for our planned operations. Future business demands may lead to cash utilization
at levels greater than recently experienced. We may need to raise additional capital in the future. However, we cannot assure you that
we will be able to raise additional capital on acceptable terms, or at all. Our inability to generate profits could have an adverse effect
on our financial condition, results of operations, and cash flows. See “Management’s Discussion and Analysis of Financial
Condition and Results of Operations; Liquidity and Capital Resources” in our Form 10-K for the fiscal year ended December 31, 2021, which is incorporated by reference herein. See
“Incorporation of Certain Information by Reference.”
Risks Related
to Ownership of Our Securities
An investment
in our securities is speculative and there can be no assurance of any return on any such investment.
An
investment in our securities is speculative and there can be no assurance that investors will obtain any return on their investment.
Investors may be subject to substantial risks involved in an investment in the Company, including the risk of losing their entire investment.
If you
purchase shares of our common stock, you may experience immediate and substantial dilution in the net tangible book value of your shares.
In addition, we may issue shares of common stock pursuant to our equity incentive plans and additional equity or convertible debt securities
in the future, which may result in additional dilution to investors.
We
are currently authorized to issue up to 200,000,000 shares of common stock. We may, in the future, issue previously authorized and unissued
shares of common stock, which would result in the dilution of current stockholders’ ownership interests. Additional shares are
subject to issuance through various equity compensation plans or the exercise of currently outstanding equity awards. The potential issuance
of additional shares of common stock may create downward pressure on the trading price of our common stock. We also may in the future
issue additional shares of common stock or other securities that are convertible into or exercisable for common stock in order to raise
capital or effectuate other business purposes. Purchasers of the shares we sell, as well as our existing stockholders, will experience
significant dilution if we sell shares at prices significantly below the price at which they invested. In addition, to the extent we
need to raise additional capital in the future and we issue additional shares of common stock or securities convertible or exchangeable
for our common stock, our then existing stockholders may experience dilution and the new securities may have rights senior to those of
our current stockholders. Any of the above events could significantly harm our business, prospects, financial condition and results of
operations and cause the price of our common stock to decline.
Our stock
price has been and may continue to be, volatile.
The
market price of our common stock has been, and may continue to be, subject to material volatility. Such fluctuations could be in response
to, among other things, the factors described in this “Risk Factors” section, or other factors, some of which are
beyond our control, such as:
|
• |
the ongoing impacts of the COVID-19 pandemic and the
resulting impact on stock market performance; |
|
• |
fluctuations in our financial results or outlook, or
those of companies perceived to be similar to us; |
|
• |
changes in the prices of commodities associated with
our business; |
|
• |
changes in our capital structure, such as future issuances
of securities or the incurrence of debt; |
|
• |
announcements by us or our competitors of significant
contracts, acquisitions or strategic partnerships; |
|
• |
regulatory developments; |
|
• |
litigation involving us or our general industry; |
|
• |
additions or departures of key personnel; and |
|
• |
changes in general economic, industry and market conditions. |
Furthermore,
stock markets have experienced price and volume fluctuations that have affected, and continue to affect, the market prices of equity
securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those
companies. These broad market fluctuations, as well as general economic, political and market conditions, such as recessions, interest
rate changes and international currency fluctuations, may negatively affect the market price of our common stock.
Additionally,
the global economy and financial markets may be adversely affected by geopolitical events, including the current or anticipated impact
of military conflict and related sanctions imposed on Russia by the United States and other countries due to Russia’s recent invasion
of Ukraine.
In
the past, many companies that have experienced volatility and sustained declines in the market price of their stock have become subject
to securities class action and derivative action litigation. Securities litigation against us could result in substantial costs and divert
our management’s attention from other business concerns, which could materially harm our business. Any insurance we maintain may
not provide adequate coverage against potential losses from such securities litigation, and if claims or losses exceed our liability
insurance coverage, our business would be adversely impacted. In addition, insurance coverage may become more expensive, which would
harm our financial condition and results of operations.
Our stock
price has been and may continue to be, volatile.
The
market price of our common stock has been, and may continue to be, subject to material volatility. Such fluctuations could be in response
to, among other things, the factors described in this “Risk Factors” section, or other factors, some of which are
beyond our control, such as:
|
• |
the ongoing impacts of the COVID-19 pandemic and the
resulting impact on stock market performance; |
|
• |
fluctuations in our financial results or outlook, or
those of companies perceived to be similar to us; |
|
• |
changes in the prices of commodities associated with
our business; |
|
• |
changes in our capital structure, such as future issuances
of securities or the incurrence of debt; |
|
• |
announcements by us or our competitors of significant
contracts, acquisitions or strategic partnerships; |
|
• |
regulatory developments; |
|
• |
litigation involving us or our general industry; |
|
• |
additions or departures of key personnel; and |
|
• |
changes in general economic, industry and market conditions. |
Furthermore,
stock markets have experienced price and volume fluctuations that have affected, and continue to affect, the market prices of equity
securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those
companies. These broad market fluctuations, as well as general economic, political and market conditions, such as recessions, interest
rate changes and international currency fluctuations, may negatively affect the market price of our common stock.
Additionally,
the global economy and financial markets may be adversely affected by geopolitical events, including the current or anticipated impact
of military conflict and related sanctions imposed on Russia by the United States and other countries due to Russia’s recent invasion
of Ukraine.
In
the past, many companies that have experienced volatility and sustained declines in the market price of their stock have become subject
to securities class action and derivative action litigation. Securities litigation against us could result in substantial costs and divert
our management’s attention from other business concerns, which could materially harm our business. Any insurance we maintain may
not provide adequate coverage against potential losses from such securities litigation, and if claims or losses exceed our liability
insurance coverage, our business would be adversely impacted. In addition, insurance coverage may become more expensive, which would
harm our financial condition and results of operations.
We may
need, but be unable, to obtain additional funding on satisfactory terms, which could impose burdensome financial restrictions on our
business.
We
have relied upon cash from financing activities and in the future, we hope to rely on revenues generated from operations to fund the
cash requirements of our activities. However, there can be no assurance that we will be able to generate any significant cash from our
operating activities in the future. Future financing may not be available on a timely basis, in sufficient amounts or on terms acceptable
to us, if at all. Any debt financing or other financing of securities senior to the common stock will likely include financial and other
covenants that will restrict our flexibility. Any failure to comply with these covenants would have a material adverse effect on our
business, prospects, financial condition, and results of operations because we could lose our existing sources of funding and impair
our ability to secure new sources of funding.
Our shares
will be subject to potential delisting if we do not maintain the listing requirements of the Nasdaq Capital Market.
Our
failure to maintain our listing and our common stock being de-listed from Nasdaq would make it more difficult for stockholders to dispose
of their common stock and more difficult to obtain accurate price quotations on our common stock.
For
example, on May 19, 2021, the Company received a written notice from the Listing Qualifications department of Nasdaq indicating that
the Company was not in compliance with Nasdaq Listing Rule 5550(a)(2), which requires a minimum closing bid price of $1.00 per share
of the Company’s common stock (the “Minimum Bid Price Requirement”). The initial notice provided the Company with 180
calendar days to regain compliance with the Minimum Bid Price Requirement. On November 16, 2021, the Company received a written letter
from the Listing Qualifications department of Nasdaq notifying the Company that Nasdaq has granted the Company an additional 180 calendar
days, or until May 16, 2022, to regain compliance with the requirement for the Company’s shares of common stock to maintain the
Minimum Bid Price Requirement. On April 22, 2022, we effected a reverse stock split of our common stock on a one-for-150 basis as part
of our plan to comply with Nasdaq’s Minimum Bid Price Requirement. On May 9, 2022, we were notified by Nasdaq that we had regained
compliance with Nasdaq’s Minimum Price Requirement.
Failure
to maintain our Nasdaq listing could negatively impact us and our stockholders by reducing the willingness of investors to hold our common
stock because of the resulting decreased price, liquidity and trading of our common stock, limited availability of price quotations,
and reduced news and analyst coverage. These developments may also require brokers trading in our common stock to adhere to more stringent
rules and may limit our ability to raise capital by issuing additional shares in the future. Delisting may adversely impact the perception
of our financial condition and cause reputational harm to investors and parties conducting business with us. Additionally, if we are
subject to delisting from Nasdaq, there can be no assurance that we would be able to list our common stock on another exchange in a timely
fashion, if at all.
The market price of our common stock
has been and is expected to be, subject to significant volatility.
The
value of our common stock may decline regardless of our operating performance or prospects. Factors affecting our market price include,
but are not limited to:
|
• |
the ongoing impacts of the COVID-19
pandemic and the resulting impact on stock market performance; |
|
• |
fluctuations in our financial results
or outlook, or those of companies perceived to be similar to us; |
|
• |
changes in the prices of commodities
associated with our business; |
|
• |
changes in our capital structure,
such as future issuances of securities or the incurrence of debt; |
|
• |
announcements by us or our competitors
of significant contracts, acquisitions or strategic partnerships; |
|
• |
regulatory developments; |
|
• |
litigation involving us or our general
industry; |
|
• |
additions or departures of key personnel;
|
|
• |
changes in general economy, industry
and market conditions; and |
|
• |
prolonged disruptions in the global
supply chain; |
|
• |
if we fail to maintain the listing
of our common stock with a U.S. national securities exchange, the liquidity of our common stock could be adversely affected. |
Recent
events have caused stock prices for many companies, including ours, to fluctuate in ways unrelated or disproportionate to their operating
performance. The general economic, political and stock market conditions that may affect the market price of our common stock are beyond
our control. The market price of our common stock at any particular time may not remain the market price in the future.
Furthermore,
stock markets have experienced price and volume fluctuations that have affected, and continue to affect, the market prices of equity
securities of many companies. These fluctuations often have been unrelated or disproportionate to the operating performance of those
companies. These broad market fluctuations, as well as general economic, political and market conditions, such as recessions, interest
rate changes and international currency fluctuations, may negatively affect the market price of our common stock.
Additionally,
the global economy and financial markets may be adversely affected by geopolitical events, including the current or anticipated impact
of military conflict and related sanctions imposed on Russia by the United States and other countries due to Russia’s recent invasion
of Ukraine.
In
the past, many companies that have experienced volatility and sustained declines in the market price of their stock have become subject
to securities class action and derivative action litigation. Securities litigation against us could result in substantial costs and divert
our management’s attention from other business concerns, which could materially harm our business. Any insurance we maintain may
not provide adequate coverage against potential losses from such securities litigation, and if claims or losses exceed our liability
insurance coverage, our business would be adversely impacted. In addition, insurance coverage may become more expensive, which would
harm our financial condition and results of operations.
If research
analysts do not publish research about our business or if they issue unfavorable commentary or downgrade our common stock, our stock
price and trading volume could decline.
The
trading market for our securities may depend in part on the research and reports that research analysts publish about us and our business.
If we do not maintain adequate research coverage, or if any of the analysts who cover us downgrade our stock or publish inaccurate or
unfavorable research about our business, the price of our common stock could decline. If one or more of our research analysts ceases
to cover our business or fails to publish reports on us regularly, demand for our securities could decrease, which could cause the price
of our common stock or trading volume to decline.
We do
not currently intend to pay dividends on our common stock in the foreseeable future, and consequently, your ability to achieve a return
on your investment will depend on an appreciation in the price of our common stock.
We
have never declared or paid cash dividends on our common stock and do not anticipate paying any cash dividends to holders of our common
stock in the foreseeable future. Consequently, investors must rely on sales of their common stock after price appreciation, which may
never occur, as the only way to realize any future gains on their investments. There is no guarantee that shares of our common stock
will appreciate in value or even maintain the price at which our stockholders have purchased their shares.
Anti-takeover
provisions in our charter documents and Nevada law could discourage delay or prevent a change of control of our Company and may affect
the trading price of our common stock.
We
are a Nevada corporation and the anti-takeover provisions of the Nevada Control Shares Acquisition Act may discourage, delay, or prevent
a change of control by limiting the voting rights of control shares acquired in a control share acquisition. In addition, our Articles
of Incorporation and Amended and Restated Bylaws (“Bylaws”) may discourage, delay or prevent a change in our management
or control over us that stockholders may consider favorable. Among other things, our Articles of Incorporation and Bylaws:
|
• |
authorize the issuance of “blank check” preferred
stock that could be issued by our Board in response to a takeover attempt; |
|
• |
provide that vacancies on our Board, including newly
created directorships, may be filled only by a majority vote of directors then in office, except a vacancy occurring by reason of
the removal of a director without cause shall be filled by vote of the stockholders; and |
|
• |
limit who may call special meetings of stockholders. |
These
provisions could have the effect of delaying or preventing a change of control, whether or not it is desired by, or beneficial to, our
stockholders.
We have
agreed to indemnify our officers and directors against lawsuits to the fullest extent of the law.
Nevada
law permits the indemnification of officers and directors against expenses incurred in successfully defending against a claim. Nevada
law also authorizes Nevada corporations to indemnify their officers and directors against expenses and liabilities incurred because of
their being or having been an officer or director. Our organizational documents provide for this indemnification to the fullest extent
permitted by Nevada law.
Insofar
as indemnification for liabilities arising under the Securities Act of 1933 may be permitted to directors, officers or persons controlling
the Company pursuant to provisions of the State of Nevada, the Company has been informed that, in the opinion of the Securities and Exchange
Commission, such indemnification is against public policy as expressed in that Act and is, therefore, unenforceable.
IN ADDITION TO
THE ABOVE RISKS, BUSINESSES ARE OFTEN SUBJECT TO RISKS NOT FORESEEN OR FULLY APPRECIATED BY MANAGEMENT. IN REVIEWING THIS FILING, POTENTIAL
INVESTORS SHOULD KEEP IN MIND THAT OTHER POSSIBLE RISKS MAY ADVERSELY IMPACT THE COMPANY’S BUSINESS OPERATIONS AND THE VALUE OF
THE COMPANY’S SECURITIES.
USE
OF PROCEEDS
All
of the shares of common stock offered by the Selling Stockholders pursuant to this prospectus will be sold by the Selling Stockholders
for their respective accounts. We will not receive any of the proceeds from these sales. However, we will receive gross proceeds of approximately
$41.5 million if all of the Warrants held by the Selling Stockholders are exercised for cash, excluding fees payable to Wainwright and
other expenses. We intend to use any of the net proceeds from Warrant exercises for working capital purposes.
DIVIDEND
POLICY
We
have not declared any cash dividends since inception, and we do not anticipate paying any dividends in the foreseeable future. Instead,
we anticipate that all of our earnings will be used to provide working capital, support our operations, and finance the growth and development
of our business. The payment of dividends is within the discretion of the Board and will depend on our earnings, capital requirements,
financial condition, prospects, applicable Nevada law, which provides that dividends are only payable out of surplus or current net profits,
and other factors our Board might deem relevant. There are no restrictions that currently limit our ability to pay dividends on our common
stock other than those generally imposed by applicable state law.
DESCRIPTION
OF CAPITAL STOCK
The
following is a summary of the rights of our common stock and preferred stock, certain provisions of our Articles of Incorporation, as
amended, and our Bylaws, as amended, and applicable law. This summary does not purport to be complete and is qualified in its entirety
by the provisions of our Articles of Incorporation, as amended, and our Bylaws, copies of which have been filed as exhibits to the registration
statement and are incorporated by reference to our registration statement, of which this prospectus forms a part.
Authorized and
Outstanding Capital Stock
Our
authorized capital stock presently consists of 200,000,000 shares of common stock, par value $0.0001 per share, and 5,000,000 shares
of “blank check” preferred stock, par value $0.0001 per share. As of August 3, 2022, we had 8,980,531 shares of common stock
issued and outstanding, and 250 shares of Series F Convertible Preferred Stock and 250 shares of Series G Convertible Preferred stock
issued and outstanding.
Common Stock
Voting
Holders
of shares of the common stock are entitled to one vote for each share held of record on matters properly submitted to a vote of our stockholders.
Stockholders are not entitled to vote cumulatively for the election of directors.
Dividends
Subject
to the dividend rights of the holders of any outstanding series of preferred stock, holders of shares of common stock will be entitled
to receive rateably such dividends, if any, when, as, and if declared by our Board out of the Company’s assets or funds legally
available for such dividends or distributions.
Liquidation
and Distribution
In
the event of any liquidation, dissolution, or winding up of the Company’s affairs, holders of the common stock would be entitled
to share rateably in the Company’s assets that are legally available for distribution to its stockholders. If the Company has any
preferred stock outstanding at such time, holders of the preferred stock may be entitled to distribution preferences, liquidation preferences,
or both. In such case, the Company must pay the applicable distributions to the holders of its preferred stock before it may pay distributions
to the holders of common stock.
Conversion,
Redemption, and Preemptive Rights
Holders
of the common stock have no preemptive, subscription, redemption or conversion rights.
Sinking
Fund Provisions
There
are no sinking fund provisions applicable to the common stock.
Preferred
Stock
Pursuant
to our articles of incorporation, our board of directors has the authority, without further action by the stockholders, to issue from
time to time up to 5,000,000 shares of preferred stock in one or more series. Our board of directors may designate the rights, preferences,
privileges, and restrictions of the preferred stock, including dividend rights, conversion rights, voting rights, redemption rights,
liquidation preference, sinking fund terms and the number of
shares constituting any series or the designation of any series. The issuance of preferred stock could have the effect of restricting
dividends on the common stock, diluting the voting power of the common stock, impairing the liquidation rights of the common stock or
delaying, deterring or preventing a change in control. Such issuance could have the effect of decreasing the market price of the common
stock. We currently have no plans to issue any shares of preferred stock.
Series F Convertible
Preferred Stock
Dividends
The holders of Series F Convertible
Preferred Stock will be entitled to dividends, on an “as if” converted basis, equal to and in the same form as dividends actually
paid on shares of common stock, when and if actually paid.
Voting
As
of the date of this prospectus, the Series F Convertible Preferred Stock has no voting rights, except that as long as any shares of Series
F Convertible Preferred Stock are outstanding, the holders of the Series F Convertible Preferred Stock will be entitled to approve, by
a majority vote of the then outstanding shares of Series F Convertible Preferred Stock if the Company seeks to (a) alter or change
adversely the powers, preferences or rights given to the Series F Convertible Preferred Stock or alter or amend the Certificate of Designation
governing the Series F Convertible Preferred Stock, (b) amend the Articles of Incorporation, as amended or other charter documents
in any manner that adversely affects any rights of the holders of the Series F Convertible Preferred Stock, (c) increase the number
of authorized shares of Series F Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.
Liquidation
Upon
any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary or a Liquidation, the then holders of the
Series F Convertible Preferred Stock shall be entitled to receive out of the assets, whether capital or surplus, of the Company the same
amount that a holder of common stock would receive if the Series F Convertible Preferred Stock were fully converted (disregarding for
such purposes any conversion limitations hereunder) to common stock which amounts shall be paid pari passu with all holders of common
stock.
Conversion
The
Series F Convertible Preferred Stock is convertible into common stock at any time after the date of issuance. The conversion rate, subject
to adjustment as set forth in the Certificate of Designation governing the Series F Convertible Preferred Stock, is determined by dividing
the stated value of the Series F Convertible Preferred Stock by $30 (the “Conversion Price”). The Conversion Price can be
adjusted as set forth in the Certificate of Designation governing the Series F Convertible Preferred Stock for stock dividends and stock
splits or the occurrence of a fundamental transaction (as defined below). Upon conversion, the shares of Series F Convertible Preferred
Stock shall resume the status of authorized but unissued shares of preferred stock of the Company.
Optional
Conversion
The
Series F Convertible Preferred Stock can be converted at the option of the holder at any time and from time to time after the date of
issuance.
Beneficial
Ownership Limitation
The
Series F Convertible Preferred Stock cannot be converted to common stock if the holder and its affiliates would beneficially own more
than 4.99% or 9.99% at the election of the holder of the outstanding common stock. However, any holder may increase or decrease such
percentage to any other percentage not in excess of 9.99% upon notice to us, provided that any increase in this limitation will not be
effective until 61 days after such notice from the holder to us and such increase or decrease will apply only to the holder providing
such notice.
Preemptive
Rights
No
holders of Series F Convertible Preferred Stock will, as holders of Series F Convertible Preferred Stock, have any preemptive rights
to purchase or subscribe for our common stock or any of our other securities.
Redemption
The
Series F Preferred Stock is not redeemable by the Company.
Series G Convertible
Preferred Stock
Dividends
The holders of Series G Convertible
Preferred Stock will be entitled to dividends, on an “as if” converted basis, equal to and in the same form as dividends actually
paid on shares of common stock, when and if actually paid.
Voting
As
of the date of this prospectus, the Series G Convertible Preferred Stock has no voting rights, except as long as any shares of Series
G Convertible Preferred Stock are outstanding, the holders of the Series G Convertible Preferred Stock will be entitled to approve, by
a majority vote of the then outstanding shares of Series G Convertible Preferred Stock if the Company seeks to (a) alter or change
adversely the powers, preferences or rights given to the Series G Convertible Preferred Stock or alter or amend the Certificate of Designation
governing the Series G Convertible Preferred Stock, (b) amend the Articles of Incorporation, as amended or other charter documents
in any manner that adversely affects any rights of the holders of the Series G Convertible Preferred Stock, (c) increase the number
of authorized shares of Series G Convertible Preferred Stock, or (d) enter into any agreement with respect to any of the foregoing.
Liquidation
Upon
any liquidation, dissolution or winding-up of the Company, whether voluntary or involuntary or a Liquidation, the then holders of the
Series G Convertible Preferred Stock shall be entitled to receive out of the assets, whether capital or surplus, of the Company the same
amount that a holder of common stock would receive if the Series G Convertible Preferred Stock were fully converted (disregarding for
such purposes any conversion limitations hereunder) to common stock which amounts shall be paid pari passu with all holders of common
stock.
Conversion
The
Series G Convertible Preferred Stock is convertible into common stock after the date of issuance. The conversion rate, subject to adjustment
as set forth in the Certificate of Designation governing the Series G Convertible Preferred Stock, is determined by dividing the stated
value of the Series G Convertible Preferred Stock by $30 (the “Conversion Price”). The Conversion Price can be adjusted as
set forth in the Certificate of Designation governing the Series G Convertible Preferred Stock for stock dividends and stock splits or
the occurrence of a fundamental transaction (as defined below). Upon conversion, the shares of Series G Convertible Preferred Stock shall
resume the status of authorized but unissued shares of preferred stock of the Company.
Beneficial
Ownership Limitation
The
Series G Convertible Preferred Stock cannot be converted to common stock if the holder and its affiliates would beneficially own more
than 4.99% or 9.99% at the election of the holder of the outstanding common stock. However, any holder may increase or decrease such
percentage to any other percentage not in excess of 9.99% upon notice to us, provided that any increase in this limitation will not be
effective until 61 days after such notice from the holder to us and such increase or decrease will apply only to the holder providing
such notice.
Preemptive
Rights
No
holders of Series G Convertible Preferred Stock will, as holders of Series G Convertible Preferred Stock, have any preemptive rights
to purchase or subscribe for our common stock or any of our other securities.
Redemption
The
Series G Preferred Stock is not redeemable by the Company.
July 2022 Private Placement of Common Stock
and Warrants
On
July 27, 2022, we consummated the closing of the Private Placement, pursuant to the terms and conditions of the Securities Purchase Agreement,
dated as of July 25, 2022 (the “Purchase Agreement”), by and among the Company and certain institutional investors named
on the signature pages thereto (the “Purchasers”). At the closing of the Private Placement, the Company issued (i) 700,000
Placement Shares, (ii) 3,300,000 Prefunded Warrants; (iii) 4,000,000 Series A Preferred Investment Options; and (iv) 4,000,000
Series B Preferred Investment Options. The purchase price of each Placement Share and associated Preferred Investment Options was $5.00
and the purchase price of each Prefunded Warrant and associated Preferred Investment Options was $4.9999.
Each
Prefunded Warrant is exercisable for $0.0001 per share of common stock until all of the Prefunded Warrants are exercised in full. Each
Series A Preferred Investment Option is exercisable for one share of common stock for $5.00 per share until the third anniversary date
of the issuance date. Each Series B Preferred Investment Option is exercisable for one share of common stock for $5.00 per share until
the second anniversary date of the issuance date. The exercise price and the number of our shares of common stock issuable upon the exercise
of each of the Warrants are subject to adjustment for stock splits, reverse splits, and similar capital transactions, as described in
the Warrants. The Preferred Warrants are exercisable on a “cashless” basis. The Preferred Investment Options may be exercised
on a “cashless basis” if there is no effective registration for the underlying shares of common stock.
A holder of the Warrants
will not have the right to exercise any portion of the Prefunded Warrants, Series A Preferred Investment Options or Series B Preferred
Investment Options, as the case may be if the holder (together with its affiliates) would beneficially own more than 4.99% or 9.99%
of the number of shares of common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined
in accordance with the terms of the Warrants. However, upon notice from the holder to the Company, the holder may increase the beneficial
ownership limitation, which may not exceed 9.99% of the number of shares of common stock outstanding immediately after giving effect to
the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants, provided that any increase in the
beneficial ownership limitation will not take effect until 61 days following notice to the Company (the “Beneficial Ownership Limitation”).
If
a fundamental transaction occurs, then the successor entity will succeed to, and be substituted for us, and may exercise every right
and power that we may exercise and will assume all of our obligations under the Warrants with the same effect as if such successor entity
had been named in such security itself. If our stockholders are given a choice as to the securities, cash or property to be received
in a fundamental transaction, then the holders of the Warrants shall be given the same choice as to the consideration it receives upon
any exercise of the Warrants following such fundamental transaction. In addition, holders of the Preferred Investment Options will have
the right to require us to repurchase its Preferred Investment Options for cash in an amount equal to the value of the remaining unexercised
portion of the Warrants based on the Black-Scholes option pricing formula. However, if the fundamental transaction is not within our
control, including not approved by our board of directors, then the holder of Preferred Investment Options will only be entitled to receive
the same type or form of consideration (and in the same proportion), at the value per share of common stock in the fundamental transaction
for each share of common stock underlying the unexercised portion of the pre-funded warrants or preferred investment options, that is
being offered and paid to our stockholder in connection with the fundamental transaction.
In
addition, if at any time the Company grants, issues or sells any common stock equivalents or rights to purchase stock, warrants, securities
or other property pro rata to the record holders of any class of shares of common stock (the “Purchase Rights”), then the
holder will be entitled to acquire, upon the terms applicable to such Purchase Rights, the aggregate Purchase Rights which the holder
could have acquired if the holder had held the number of shares of common stock acquirable upon complete exercise of its Warrants (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation) immediately before
the date on which a record is taken for the grant, issuance or sale of such Purchase Rights, or, if no such record is taken, the date
as of which the record holders of shares of common stock are to be determined for the grant, issue or sale of such Purchase Rights (provided,
however, that, to the extent that the holder’s right to participate in any such Purchase Right would result in the holder exceeding
the Beneficial Ownership Limitation, then the holder shall not be entitled to participate in such Purchase Right to such extent (or beneficial
ownership of such shares of common stock as a result of such Purchase Right to such extent) and such Purchase Right to such extent
shall be held in abeyance for the holder until such time, if ever, as its right thereto would not result in the holder exceeding the
Beneficial Ownership Limitation).
During
such time as the Warrants are outstanding, if the Company shall declare or make any dividend or other distribution of its assets (or
rights to acquire its assets) to holders of shares of common stock, by way of return of capital or otherwise (including, without
limitation, any distribution of cash, stock or other securities, property or options by way of a dividend, spin-off, reclassification,
corporate rearrangement, scheme of arrangement or other similar transaction) (a “Distribution”), then, in each such
case, the holders of the Warrants shall be entitled to participate in such Distribution to the same extent that the holders would have
participated therein if the holders had held the number of shares of common stock acquirable upon complete exercise of the Warrants (without
regard to any limitations on exercise hereof, including without limitation, the Beneficial Ownership Limitation).
All
of the Purchasers were “accredited investors” as such term is defined in Rule 501(a) under the Securities Act. The Placement
Shares and Warrants were offered pursuant to the exemptions provided in Section 4(a)(2) under the Securities Act and/or Rule 506(b) of
Regulation D promulgated thereunder, and they were not offered pursuant to this prospectus or another prospectus. Accordingly, the Selling
Stockholders may sell the Placement Shares and, upon the exercise of the Warrants, the Warrant Shares only pursuant to an effective registration
statement under the Securities Act covering the resale of those shares, an exemption under Rule 144 under the Securities Act or another
applicable exemption under the Securities Act.
In connection with the Private
Placement, we entered into a Registration Rights Agreement with the Purchasers, dated July 25, 2022 (the “Registration Rights Agreement”).
The Registration Rights Agreement provides that we shall file a registration statement covering the resale of all of the Registrable Securities
(as defined in the Registration Rights Agreement) with the SEC no later than ten calendar days after the date of the Registration
Rights Agreement, or August 4, 2022, and have the registration statement declared effective by the SEC as promptly as possible after the
filing thereof, but in any event no later than the 45th calendar date after the date of the Registration Rights Agreement,
or September 8, 2022, or, in the event of a “full review” by the SEC, the 75th day after the date of the Registration
Statement, or October 8, 2022.
Upon
the occurrence of any Event (as defined in the Registration Rights Agreement), which, among others, prohibits the Purchasers from reselling
the Securities for more than ten (10) consecutive calendar days or more than an aggregate of fifteen (15) calendar days during
any 12-month period, we are obligated to pay to each Purchaser, on each monthly anniversary of each such Event, an amount in cash, as
partial liquidated damages and not as a penalty, equal to the product of 2.0% multiplied by the aggregate subscription amount paid by
such Purchaser pursuant to the Purchase Agreement. If the Company fails to pay any partial liquidated damages in full within seven days
after the date payable, the Company will pay interest thereon at a rate of 12% per annum (or such lesser maximum amount that is permitted
to be paid by applicable law) to the holder, accruing daily from the date such partial liquidated damages are due until such amounts,
plus all such interest thereon, are paid in full.
Subject
to certain exceptions, neither we nor any of our security holders (other than the Purchasers in such capacity pursuant thereto) may
include the securities of the Company in any registration statements other than the Securities. We may not file any other registration
statements until all Securities are registered pursuant to a registration statement that is declared effective by the SEC, provided that
we may file amendments to registration statements filed prior to the date of the Registration Rights Agreement so long as no new securities
are registered on any such existing registration statements.
June 2022 Public
Offering of Units and Prefunded Units
On
June 22, 2022, we completed a public offering of (i) 772,157 units (“Units”), each Unit consisting of one share of common
stock and one warrant to purchase one share of common stock (each, a “Warrant”) for $1.90 per Unit; and (ii) 2,385,738
prefunded units (“Prefunded Units”), each Prefunded Unit consisting of one prefunded warrant (a “Prefunded Warrant”) to
purchase one share of common stock and one Warrant, for $1.8999 per Prefunded Unit. Subject to certain ownership limitations described
in the Warrants, the Warrants have an exercise price of $1.90 per share of common stock, are exercisable upon issuance and will expire
five years from the date of issuance. The exercise price of the Warrants is subject to adjustment for stock splits, reverse splits, and
similar capital transactions as described in the warrants. In connection with the offering, the Company issued Warrants to purchase an
aggregate of 3,157,895 shares of common stock.
Subject
to certain ownership limitations described in the Prefunded Warrants, the Prefunded Warrants are immediately exercisable and may be exercised
at a nominal consideration of $0.0001 per share of common stock any time until all of the Prefunded Warrants are exercised in full. A
holder will not have the right to exercise any portion of the Warrants or the Prefunded Warrants if the holder (together with its affiliates) would
beneficially own in excess of 4.99% (or, at the election of the holder, 9.99%) of the number of shares of common stock outstanding
immediately after giving effect to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants
or the Prefunded Warrants, respectively. However, upon notice from the holder to the Company, the holder may increase the beneficial
ownership limitation, which may not exceed 9.99% of the number of shares of common stock outstanding immediately after giving effect
to the exercise, as such percentage ownership is determined in accordance with the terms of the Warrants or the Prefunded Warrants, respectively,
provided that any increase in the beneficial ownership limitation will not take effect until 61 days following notice to the Company.
As
compensation to Wainwright, as the exclusive placement agent in connection with the offering, the Company paid the Placement Agent a
cash fee of 7% of the aggregate gross proceeds raised in the offering, plus a management fee equal to 0.5% of the gross proceeds raised
in the offering and reimbursement of certain expenses and legal fees. The Company also issued to designees of the Wainwright Agent warrants
to purchase up to 189,474 shares of common stock (the “Placement Agent Warrants”). The Placement Agent Warrants have substantially
the same terms as the Warrants, except that the Placement Agent Warrants have an exercise price equal to $2.375 per share, and expire
on the fifth anniversary from the date of the commencement of sales in the offering.
In
connection with the offering, the Company entered into a Securities Purchase Agreement (the “Purchase Agreement”) with
certain institutional investors on June 17, 2022. The Purchase Agreement contained customary representations and warranties and agreements
of the Company and the Purchasers and customary indemnification rights and obligations of the parties.
The
shares of common stock and Warrants underlying the Units, the Warrants and Prefunded Warrants underlying the Prefunded Units and the
Placement Agent Warrants described above and the underlying shares of common stock were offered pursuant to the Registration Statement
on Form S-1 (File No. 333-264930), as amended, which was declared effective by the Securities and Exchange Commission on June 17, 2022.
The
Company received net proceeds of approximately $5.1 million from the offering, after deducting the estimated offering expenses payable
by the Company, including the Placement Agent fees. The Company intends to use the net proceeds from the offering for general corporate
purposes, including working capital, and the repurchase of certain existing warrants.
Series A Warrants
In
our November 2018 initial public offering and concurrent private placement, we issued units that included a total of 4,875 Series A Warrants.
Exercisability
The
warrants are exercisable at any time after their original issuance and at any time up to the date that is five years after their original
issuance for the Series A Warrants The warrants will be exercisable, at the option of each holder, in whole or in part by delivering
to us a duly executed exercise notice and, at any time a registration statement registering the issuance of the shares of common stock
underlying the warrants under the Securities Act is effective and available for the issuance of such shares, or an exemption from registration
under the Securities Act is available for the issuance of such shares, by payment in full in immediately available funds for the number
of shares of common stock purchased upon such exercise. If a registration statement registering the issuance of the shares of common
stock underlying the warrants under the Securities Act is not effective or available and an exemption from registration under the Securities
Act is not available for the issuance of such shares, the holder may, in its sole discretion, elect to exercise the warrant through a
cashless exercise, in which case the holder would receive upon such exercise the net number of shares of common stock determined according
to the formula outlined in the warrant. No fractional shares of common stock will be issued in connection with the exercise of a warrant.
In place of fractional shares, we will pay the holder an amount in cash equal to the fractional amount multiplied by the exercise price
Exercise
Limitation
A
holder will not have the right to exercise any portion of the warrant if the holder (together with its affiliates) would beneficially
own in excess of 9.99% of the number of shares of our common stock outstanding immediately after giving effect to the exercise, as such
percentage ownership is determined in accordance with the terms of the warrants.
Exercise
Price
The
weighted average exercise price per whole share of common stock purchasable upon exercise of the warrants is $7,758 per share for the
Series A Warrants. The exercise price is subject to appropriate adjustment in the event of certain stock dividends and distributions,
stock splits, stock combinations, reclassifications or similar events affecting our common stock and also upon any distributions of assets,
including cash, stock or other property to our stockholders.
Transferability
Subject
to applicable laws, the warrants may be offered for sale, sold, transferred or assigned without our consent.
Fundamental
Transactions
In
the event of a fundamental transaction, as described in the warrants and generally including any reorganization, recapitalization or
reclassification of our common stock, the sale, transfer or other disposition of all or substantially all of our properties or assets,
our consolidation or merger with or into another person, the acquisition of more than 50% of our outstanding common stock, or any person
or group becoming the beneficial owner of 50% of the voting power represented by our outstanding common stock, the holders of the warrants
are entitled to receive upon exercise of the warrants the kind and amount of securities, cash or other property that the holders would
have received had they exercised the warrants immediately prior to such fundamental transaction.
Rights as
a Stockholder
Except
as otherwise provided in the warrants or by virtue of such holder’s ownership of shares of our common stock, the holder of a warrant
does not have the rights or privileges of a holder of our common stock, including any voting rights, until the holder exercises the warrant.
Governing
Law
The
Series A Warrants and the warrant agency agreement are governed by New York law.
Anti-Takeover
Effects of Nevada Law and the Articles of Incorporation and Bylaws
Certain
provisions of the Articles of Incorporation and Bylaws, and certain provisions of the NRS could make our acquisition by a third party,
a change in our incumbent management, or a similar change of control more difficult. These provisions, which are summarized below, are
likely to reduce our vulnerability to an unsolicited proposal for the restructuring or sale of all or substantially all of our assets
or an unsolicited takeover attempt. The summary of the provisions set forth below does not purport to be complete and is qualified in
its entirety by reference to the Articles of Incorporation and the Bylaws and the relevant provisions of the NRS.
Authorized but
Unissued Shares
Our
authorized but unissued shares of common stock and preferred stock are available for future issuance, subject to any limitations imposed
by the listing standards of the Nasdaq Capital Market. These additional shares may be used for a variety of corporate finance transactions,
acquisitions and employee benefit plans. The existence of authorized but unissued and unreserved common stock and preferred stock could
make it more difficult or discourage an attempt to obtain control of us by means of a proxy contest, tender offer, merger or otherwise.
Our
authorized capital includes “blank check” preferred stock. Our Board has the authority to issue preferred stock in one or
more classes or series and determine the price, designation, rights, preferences, privileges, restrictions and conditions, including
voting and dividend rights, of those shares without any further vote or action by stockholders. The rights of the holders of common stock
will be subject to and may be adversely affected by, the rights of holders of any preferred stock that may be issued in the future. The
issuance of additional preferred stock, while providing desirable flexibility in connection with possible financings and acquisitions
and other corporate purposes, could make it more difficult for a third party to acquire a majority of the voting power of our outstanding
voting securities, which could deprive our holders of common stock of a premium that they might otherwise realize in connection with
a proposed acquisition of our Company.
Action by Written
Consent
Our
Bylaws provide that any action required or permitted by law, the Articles of Incorporation or Bylaws to be taken at a meeting of the
stockholders of the Company may be taken without a meeting if a consent or consents in writing, setting forth the action so taken, shall
be signed by stockholders holding at least a majority of the voting power; provided that if a different proportion of voting power is
required for such an action at a meeting, then that proportion of written consents is required.
Advance Notice
Requirements
Stockholders
wishing to nominate persons for election to our Board at a meeting or to propose any business to be considered by our stockholders at
a meeting must comply with certain advance notice and other requirements set forth in our Bylaws and Rule 14a-8 of the Exchange Act.
Special Meetings
Our
Bylaws provide that special meetings of stockholders may only be called by the President or Chief Executive Officer. Business transacted
at all special meetings shall be confined to the purposes stated in the notice of the meeting unless all stockholders entitled to vote
are present and consent.
Board Vacancies
Our
Bylaws provide that any vacancy on our Board, howsoever resulting, may be filled by a majority vote of the remaining directors.
Removal of Directors
Our
Bylaws provide that any director may be removed either for or without cause at any special meeting of stockholders by the affirmative
vote of at least two-thirds of the voting power of the issued and outstanding stock entitled to vote; provided, however, that notice
of intention to act upon such matter shall have been given in the notice calling such meeting.
Right to Alter,
Amend or Repeal Bylaws
Our
Bylaws provide that they may be altered, amended or repealed at any meeting of the Board at which a quorum is present, by the affirmative
vote of a majority of the Directors present at such meeting.
Indemnification
of Officers and Directors and Insurance
Our
Bylaws provide for the limitation of liability of our directors and the indemnification of our directors and officers to the fullest
extent permitted under Nevada law. Our directors and officers may be liable for a breach or failure to perform their duties in accordance
with Nevada law only if their breach or failure to perform constitutes gross negligence, willful misconduct or intentional harm to our
Company or our stockholders. Our directors may not be personally liable for monetary damages for action taken or failure to take action
as a director except in specific instances established by Nevada law.
Under
Nevada law, we may generally indemnify a director or officer against liability incurred in a proceeding if he or she acted in good faith
and believed that his or her conduct was in our best interest and that he or she had no reason to believe his or her conduct was unlawful.
We may not indemnify a director or officer if the person was adjudged liable to us or in the event it is adjudicated that the director
or officer received an improper personal benefit.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons
pursuant to the foregoing provisions, or otherwise, we have been advised that in the opinion of the U.S. Securities and Exchange Commission,
such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable.
Nevada Anti-Takeover
Statutes
The
NRS contains provisions restricting the ability of a Nevada corporation to engage in business combinations with an interested stockholder.
Under the NRS, except under certain circumstances, business combinations with interested stockholders are not permitted for a period
of two years following the date such stockholder becomes an interested stockholder. The NRS defines an interested stockholder, generally,
as a person who is the beneficial owner, directly or indirectly, of 10% of the outstanding shares of a Nevada corporation. In addition,
the NRS generally disallows the exercise of voting rights with respect to “control shares” of an “issuing corporation”
held by an “acquiring person,” unless such voting rights are conferred by a majority vote of the disinterested stockholders.
“Control shares” are those outstanding voting shares of an issuing corporation which an acquiring person and those persons
acting in association with an acquiring person (i) acquire or offer to acquire in an acquisition of a controlling interest and (ii) acquire
within 90 days immediately preceding the date when the acquiring person became an acquiring person. An “issuing corporation”
is a corporation organized in Nevada that has two hundred or more stockholders, at least one hundred of who are stockholders of record
and residents of Nevada, and which does business in Nevada directly or through an affiliated corporation. The NRS also permits directors
to resist a change or potential change in control of the corporation if the directors determine that the change or potential change is
opposed to or not in the best interest of the corporation.
Options
As
of August 3, 2022, the Company had 1,354 stock options and RSUs issued and outstanding.
Warrants
As
of August 3, 2022, the Company had 8,893,473 warrants issued and outstanding.
Nevada Business Combination
Statutes
The
“business combination” provisions of Sections 78.411 to 78.444, inclusive, of the Nevada Revised Statutes, (the “NRS”),
generally prohibit a Nevada corporation with at least 200 stockholders of record from engaging in various “combination” transactions
with any interested stockholder for two years after the date of the transaction in which the person became an interested stockholder
unless the transaction is approved by the Board before the date the interested stockholder obtained such status or the combination is
approved by the Board and thereafter is approved at a meeting of the stockholders by the affirmative vote of stockholders representing
at least 60% of the outstanding voting power held by disinterested stockholders, and extends beyond the expiration of the two-year period,
unless:
|
• |
the combination
was approved by the Board prior to the person becoming an interested stockholder or the transaction by which the person first became
an interested stockholder was approved by the Board before the person became an interested stockholder or the combination is later
approved by a majority of the voting power held by disinterested stockholders; or |
|
• |
if the consideration
to be paid by the interested stockholder is at least equal to the highest of: (a) the highest price per share paid by the interested
stockholder within the two years immediately preceding the date of the announcement of the combination or in the transaction in which
it became an interested stockholder, whichever is higher, (b) the market value per share of common stock on the date of announcement
of the combination and the date the interested stockholder acquired the shares, whichever is higher, or (c) for holders of preferred
stock, the highest liquidation value of the preferred stock, if it is higher. |
A
“combination” is generally defined to include mergers or consolidations or any sale, lease exchange, mortgage, pledge,
transfer, or other disposition, in one transaction or a series of transactions, with an “interested stockholder” having:
(a) an aggregate market value equal to 5% or more of the aggregate market value of the assets of the corporation, (b) an aggregate
market value equal to 5% or more of the aggregate market value of all outstanding voting shares of the corporation, (c) more than
10% of the earning power or net income of the corporation, and (d) certain other transactions with an interested stockholder or
an affiliate or associate of an interested stockholder.
In
general, an “interested stockholder” is a person who, together with affiliates and associates, beneficially owns (or within
two years, did own) 10% or more of the voting power of the outstanding voting shares of a corporation. The statute could prohibit
or delay mergers or other takeover or change in control attempts and, accordingly, may discourage attempts to acquire us even though
such a transaction may offer our stockholders the opportunity to sell their stock at a price above the prevailing market price.
Transfer Agent and
Registrar
Our
transfer agent and registrar is Vstock Transfer, LLC located at 18 Lafayette Pl, Woodmere, New York 11598. Their telephone number is
(212) 828-8436.
Nasdaq Capital Market
Our
common stock and Series A Warrants are listed on the Nasdaq Capital Market under the symbol “TBLT” and “TBLTW,”
respectively.
Penny Stock Regulation
The
SEC has adopted regulations that generally define “penny stock” to be any equity security that has a market price of less
than five dollars ($5.00) per share or an exercise price of less than five dollars ($5.00) per share. Such securities are subject
to rules that impose additional sales practice requirements on broker-dealers who sell them. For transactions covered by these rules,
the broker-dealer must make a special suitability determination for the purchaser of such securities and have received the purchaser’s
written consent to the transaction prior to the purchase. Additionally, for any transaction involving a penny stock, unless exempt, the
rules require the delivery, prior to the transaction, of a disclosure schedule prepared by the SEC relating to the penny stock market.
The broker-dealer also must disclose the commissions payable to both the broker-dealer and the registered representative, current quotations
for the securities and, if the broker-dealer is the sole market maker, the broker-dealer must disclose this fact and the broker-dealer’s
presumed control over the market. Finally, among other requirements, monthly statements must be sent disclosing recent price information
for the penny stock held in the account and information on the limited market in penny stocks. As our common stock immediately following
this offering may be subject to such penny stock rules, purchasers in this offering will in all likelihood find it more difficult to
sell their common stock shares in the secondary market.
Dividend Policy
To
date, we have never declared a dividend for our common stock. We currently intend to retain future earnings, if any, to finance the expansion
of our business and for general corporate purposes. We cannot assure you that we will distribute any cash in the future. Our cash distribution
policy is within the discretion of our Board and will depend upon various factors, including our results of operations, financial condition,
capital requirements and investment opportunities.
PLAN
OF DISTRIBUTION
Each
Selling Stockholder and any of their pledgees, assignees and successors-in-interest may, from time to time, sell any or all of their
securities covered hereby on the Nasdaq Capital Market or any other stock exchange, market or trading facility on which the securities
are traded or in private transactions. These sales may be at fixed or negotiated prices. A Selling Stockholder may use any one or more
of the following methods when selling securities:
| · | ordinary
brokerage transactions and transactions in which the broker-dealer solicits purchasers; |
| · | block
trades in which the broker-dealer will attempt to sell the securities as agent but may position
and resell a portion of the block as principal to facilitate the transaction; |
| · | purchases
by a broker-dealer as principal and resale by the broker-dealer for its account; |
| · | an
exchange distribution in accordance with the rules of the applicable exchange; |
| · | privately
negotiated transactions; |
| · | settlement
of short sales; |
| · | in
transactions through broker-dealers that agree with the Selling Stockholders to sell a specified
number of such securities at a stipulated price per security; |
| · | through
the writing or settlement of options or other hedging transactions, whether through an options
exchange or otherwise; |
| · | a
combination of any such methods of sale; or |
| · | any
other method permitted pursuant to applicable law. |
The
Selling Stockholders may also sell securities under Rule 144 or any other exemption from registration under the Securities Act, if available,
rather than under this prospectus.
Broker-dealers
engaged by the Selling Stockholders may arrange for other broker-dealers to participate in sales. Broker-dealers may receive commissions
or discounts from the Selling Stockholders (or, if any broker-dealer acts as agent for the purchaser of securities, from the purchaser) in
amounts to be negotiated, but except as set forth in a supplement to this Prospectus, in the case of an agency transaction not in excess
of a customary brokerage commission in compliance with FINRA Rule 2121; and in the case of a principal transaction a markup or markdown
in compliance with FINRA Rule 2121.
In
connection with the sale of the securities or interests therein, the Selling Stockholders may enter into hedging transactions with broker-dealers
or other financial institutions, which may, in turn, engage in short sales of the securities in the course of hedging the positions they
assume. The Selling Stockholders may also sell securities short and deliver these securities to close out their short positions, or loan
or pledge the securities to broker-dealers that in turn may sell these securities. The Selling Stockholders may also enter into option
or other transactions with broker-dealers or other financial institutions or create one or more derivative securities which require the
delivery to such broker-dealer or other financial institution of securities offered by this prospectus, which securities such broker-dealer
or other financial institution may resell pursuant to this prospectus (as supplemented or amended to reflect such transaction).
The
Selling Stockholders and any broker-dealers or agents that are involved in selling the securities may be deemed to be “underwriters”
within the meaning of the Securities Act in connection with such sales. In such event, any commissions received by such broker-dealers
or agents and any profit on the resale of the securities purchased by them may be deemed to be underwriting commissions or discounts
under the Securities Act. Each Selling Stockholder has informed the Company that it does not have any written or oral agreement or understanding,
directly or indirectly, with any person to distribute the securities.
The
Company is required to pay certain fees and expenses incurred by the Company incident to the registration of the securities. The Company
has agreed to indemnify the Selling Stockholders against certain losses, claims, damages and liabilities, including liabilities under
the Securities Act.
We
agreed to keep this prospectus effective until the earlier of (i) the date on which the securities may be resold by the Selling
Stockholders without registration and without regard to any volume or manner-of-sale limitations by reason of Rule 144, without the requirement
for the Company to be in compliance with the current public information under Rule 144 under the Securities Act or any other rule of
similar effect or (ii) all of the securities have been sold pursuant to this prospectus or Rule 144 under the Securities Act or
any other rule of similar effect. The resale securities will be sold only through registered or licensed brokers or dealers if required
under applicable state securities laws. In addition, in certain states, the resale securities covered hereby may not be sold unless they
have been registered or qualified for sale in the applicable state or an exemption from the registration or qualification requirement
is available and is complied with.
Under
applicable rules and regulations under the Exchange Act, any person engaged in the distribution of the resale securities may not simultaneously
engage in market making activities with respect to the common stock for the applicable restricted period, as defined in Regulation M,
prior to the commencement of the distribution. In addition, the Selling Stockholders will be subject to applicable provisions of the
Exchange Act and the rules and regulations thereunder, including Regulation M, which may limit the timing of purchases and sales of the
common stock by the Selling Stockholders or any other person. We will make copies of this prospectus available to the Selling Stockholders
and have informed them of the need to deliver a copy of this prospectus to each purchaser at or prior to the time of the sale (including
by compliance with Rule 172 under the Securities Act).
SELLING
STOCKHOLDERS
The common stock being offered
by the Selling Stockholders are those previously issued to the Selling Stockholders, and those issuable to the Selling Stockholders, upon
exercise of the warrants. For additional information regarding the issuances of those shares of common stock and warrants, see “July
2022 Private Placement of Common Stock and Warrants” above. We are registering the shares of common stock in order to permit the
Selling Stockholders to offer the shares for resale from time to time. Except for the ownership of the shares of common stock and the
warrants, the Selling Stockholders have not had any material relationship with us within the past three years.
The
table below lists the Selling Stockholders and other information regarding the beneficial ownership of the shares of common stock by
each of the Selling Stockholders. The second column lists the number of shares of common stock beneficially owned by each Selling Stockholder,
based on its ownership of the shares of common stock and warrants, as of August 3, 2022, assuming the exercise of the warrants held by
the Selling Stockholders on that date, without regard to any limitations on exercises.
The
third column lists the shares of common stock being offered by this prospectus by the Selling Stockholders.
In accordance with the terms
of a registration rights agreement with the Selling Stockholders, this prospectus generally covers the resale of the sum of (i) the
number of shares of common stock issued to the Selling Stockholders in the “July 2022 Private Placement of Common Stock and Warrants”
described above and (ii) the maximum number of shares of common stock issuable upon exercise of the related warrants, determined
as if the outstanding warrants were exercised in full as of the trading day immediately preceding the date this registration statement
was initially filed with the SEC, each as of the trading day immediately preceding the applicable date of determination and all subject
to adjustment as provided in the registration right agreement, without regard to any limitations on the exercise of the warrants. The
fourth column assumes the sale of all of the shares offered by the Selling Stockholders pursuant to this prospectus.
Under
the terms of the warrants and other warrants held by Selling Stockholders, a Selling Stockholder may not exercise any such warrants to
the extent such exercise would cause such Selling Stockholder, together with its affiliates and attribution parties, to beneficially
own a number of shares of common stock which would exceed 4.99% or 9.99%, as applicable, of our then outstanding common stock following
such exercise, excluding for purposes of such determination shares of common stock issuable upon exercise of such warrants which have
not been exercised. The number of shares in the second and fourth columns do not reflect this limitation. The Selling Stockholders may
sell all, some or none of their shares in this offering. See “Plan of Distribution.”
Name of Selling Stockholder | |
Number of Shares of Common Stock
Owned Prior to Offering (1) | | |
Maximum Number of Shares of Common
Stock to be Sold Pursuant to this Prospectus (2) | | |
Number of Shares of Common Stock
Owned After Offering (3) | | |
Percentage of Beneficial Ownership
After Offering (4) | |
| |
| | |
| | |
| | |
| |
Sabby Volatility Warrant Master Fund, Ltd. (5) | |
| 7,500,000 | (6) | |
| 7,500,000 | | |
| — | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Alto Opportunity Master Fund, SPC – Segregated Master Fund Ltd. (7) | |
| 2,591,498 | (8) | |
| 2,400,000 | | |
| 191,600 | | |
| * | |
| |
| | | |
| | | |
| | | |
| | |
Armistice Capital Master Fund Ltd.(9) | |
| 1,866,231 | (10) | |
| 1,800,000 | | |
| 86,231 | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Intracoastal Capital LLC (11) | |
| 341,330 | (12) | |
| 300,000 | | |
| 41,330 | | |
| * | |
| |
| | | |
| | | |
| | | |
| | |
Michael Vasinkevich (13) | |
| 153,900 | | |
| 153,990 | | |
| — | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Michael Mirsky (13) | |
| 45,600 | | |
| 45,600 | | |
| — | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Noam Rubenstein (13) | |
| 30,000 | | |
| 30,000 | | |
| — | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Craig Schwabe (13) | |
| 8,100 | | |
| 8,100 | | |
| — | | |
| — | |
| |
| | | |
| | | |
| | | |
| | |
Charles Worthman (13) | |
| 2,400 | | |
| 2,400 | | |
| — | | |
| — | |
*Less than 1%.
| (1) | Consists of shares of common stock and
shares of common stock issuable pursuant to the full exercise of the Warrants issued in the
Private Placement and other warrants previously acquired from the Company. |
| (2) | Represents shares of common stock issued
to the Selling Stockholders in the Private Placement and shares of common stock owned by
the Selling Stockholders upon the full exercise of the Warrants offered hereby. All of the
Warrants that are exercisable for the Warrant Shares offered hereby contain certain beneficial
ownership limitations, which provide that a holder of the Warrants will not have the right
to exercise any portion of its Warrants if such holder, together with its affiliates and
attribution parties, would beneficially own in excess of 4.99% or 9.99%, as applicable, of
the number of shares of common stock outstanding immediately after giving effect to such
exercise, provided that upon at least 61 days prior notice to us, a holder may increase or
decrease such limitation up to a maximum of 9.99% of the number of shares of common stock
outstanding (each such limitation, a “Beneficial Ownership Limitation”). |
| (3) | We do not know when or in what amounts
a Selling Stockholder may offer shares for sale. The Selling Stockholders might not sell
any or might sell all of the shares offered by this prospectus. Because the Selling Stockholders
may offer all or some of the shares pursuant to this offering, and because there are currently
no agreements, arrangements or understandings with respect to the sale of any of the shares,
we cannot estimate the number of the shares that will be held by the Selling Stockholders
after completion of the offering. However, for purposes of this table, we have assumed that,
after completion of the offering, none of the shares covered by this prospectus will be held
by the Selling Stockholders, including common stock issuable upon exercise of the Warrants
issued in the Private Placement. |
| (4) | Based on 20,520,531 shares of common
stock, assuming the full exercise of the Warrants and the Placement Agent Warrants. |
| (5) | Sabby Management, LLC is the investment
manager of Sabby Volatility Warrant Master Fund, Ltd. and shares voting and investment power
with respect to these shares in this capacity. As manager of Sabby Management, LLC, Hal Mintz
also shares voting and investment power on behalf of Sabby Volatility Warrant Master Fund,
Ltd. Hal Mintz disclaims beneficial ownership over the securities listed except to the extent
of their pecuniary interest therein. |
| (6) | Includes 7,500,000 Warrants that are
not presently fully exercisable as a result of the 4.99% Beneficial Ownership Limitation. |
| (7) | Ayrton Capital LLC, the investment manager
to Alto Opportunity Master Fund, SPC - Segregated Master Portfolio B, has discretionary authority
to vote and dispose of the shares held by Alto Opportunity Master Fund, SPC - Segregated
Master Portfolio B and may be deemed to be the beneficial owner of these shares. Waqas Khatri,
in his capacity as Managing Member of Ayrton Capital LLC, may also be deemed to have investment
discretion and voting power over the shares held by Alto Opportunity Master Fund, SPC - Segregated
Master Portfolio B. Ayrton Capital LLC and Mr. Khatri each disclaim any beneficial ownership
of these shares. The address of Ayrton Capital LLC is 55 Post Rd West, 2nd Floor, Westport,
CT 06880. |
| (8) | Includes (i) 2,400,000 Warrants that
are not presently fully exercisable as a result of a 4.99% Beneficial Ownership Limitation;
(ii) 161,816 Series A Warrants; and (iii) 29,682 warrants that are not fully exercisable
as a result of a 4.99% Beneficial Ownership Limitation. |
| (9) | The securities reported herein are held
by Armistice Capital Master Fund Ltd., a Cayman Islands exempted company (the “Master
Fund”), and may be deemed to be indirectly beneficially owned by: (i) Armistice
Capital, LLC (“Armistice Capital”), as the investment manager of the Master Fund;
and (ii) Steven Boyd, as the Managing Member of Armistice Capital. Armistice Capital
and Steven Boyd disclaim beneficial ownership of the securities except to the extent of their
respective pecuniary interests therein. The address of the Master Fund is c/o Armistice Capital,
LLC, 510 Madison Ave, 7th Floor, New York, NY 10022. |
| (10) | Includes (i) 1,200,000 Preferred Investment
Options that are not presently fully exercisable as a result of a 4.99% Beneficial Ownership
Limitation; and (ii) 8,623.90 warrants that are not fully exercisable as a result of a 4.99%
Beneficial Ownership Limitation. |
| (11) | Mitchell P.
Kopin and Daniel B. Asher, each of whom is a manager of Intracoastal Capital LLC, have shared
voting control and investment discretion over the securities reported herein that are held
by Intracoastal Capital LLC. As a result, each of Mr. Kopin and Mr. Asher may be
deemed to have beneficial ownership of the securities reported herein that are held by Intracoastal
Capital LLC. Mr. Kopin and Mr. Asher disclaim beneficial
ownership of the securities except to the extent of their respective pecuniary interests
therein. The address for Intracoastal Capital LLC is 2211A Lakeside Drive Bannockburn, IL
60015. |
| (12) | Includes 200,000 Preferred Investment
Options that are not presently fully exercisable as a result of a 9.99% Beneficial Ownership
Limitation. |
| (13) | The Selling Stockholder is affiliated
with H.C. Wainwright & Co., LLC, a registered broker-dealer, and has a registered address
of c/o H.C. Wainwright & Co., LLC, 430 Park Ave, 3rd Floor, New York, NY 10022. The Selling
Stockholder purchased the Warrants in the ordinary course of business and, at the time of
purchase of the securities that are registered for resale, the Selling Stockholders had no
agreements or understanding, directly or indirectly with any person to distribute securities. |
EXPERTS
Our
consolidated financial statements for the fiscal years ended December 31, 2021 and 2020 included in our Annual Report on Form 10-K for
the fiscal year ended December 31, 2021 and incorporated by reference into this prospectus have been audited by Marcum LLP, an independent
registered public accounting firm, as stated in their report, which is incorporated herein by reference. Such consolidated financial
statements have been so incorporated in reliance upon the report of such firm (which report expresses an unqualified opinion and includes
an explanatory paragraph regarding the Company’s going concern uncertainty) given upon their authority as experts in auditing
and accounting.
LEGAL
MATTERS
Carmel,
Milazzo & Feil LLP, New York, New York, is acting as counsel in connection with the registration of our securities under the Securities
Act, and as such, will pass upon the validity of the securities offered in this prospectus.
WHERE
YOU CAN FIND MORE INFORMATION
We
have filed with the SEC a registration statement on Form S-1 under the Securities Act with respect to the common stock offered in this
prospectus. This prospectus, which constitutes a part of the registration statement, does not contain all of the information set forth
in the registration statement and its exhibits and schedules, portions of which have been omitted as permitted by the rules and regulations
of the SEC. For further information about us and our common stock, we refer you to the registration statement and to its exhibits and
schedules. Statements in this prospectus about the contents of any contract, agreement or other document are not necessarily complete
and, in each instance, we refer you to the copy of such contract, agreement or document filed as an exhibit to the registration statement,
with each such statement being qualified in all respects by reference to the document to which it refers. Anyone may inspect and copy
the registration statement and its exhibits and schedules at the Public Reference Room the SEC maintains at 100 F Street, N.E., Washington,
D.C. 20549. You may obtain further information about the operation of the SEC’s Public Reference Room by calling the SEC at 1-800-SEC-0330.
You may also inspect the registration statement and its exhibits and schedules and other information without charge at the website maintained
by the SEC. The address of this site is www.sec.gov.
We
also file periodic reports, proxy statements and other information with the SEC. These reports, proxy statements and other information
will be available for inspection and copying at the public reference room and website of the SEC referred to above. We also maintain
a website at www.toughbuilt.com, by which you may access these materials free of charge as soon as reasonably practicable
after they are electronically filed with, or furnished to, the SEC. The information that is contained on, or that may be accessed through,
our website is not a part of this prospectus. We have included our website in this prospectus solely as an inactive textual reference.
INCORPORATION
OF CERTAIN INFORMATION BY REFERENCE
This
prospectus omits some information contained in the registration statement in accordance with SEC rules and regulations. You should review
the information and exhibits included in the registration statement of which this prospectus is a part for further information about
us and the securities we are offering. Statements in this prospectus concerning any document we filed as an exhibit to the registration
statement or that we otherwise filed with the SEC are not intended to be comprehensive and are qualified by reference to these filings.
You should review the complete document to evaluate these statements.
The
SEC allows us to “incorporate by reference” information we file with it, which means that we can disclose important information
to you by referring you to other documents. The information incorporated by reference is considered to be a part of this prospectus.
Information contained in this prospectus supersedes information incorporated by reference that we have filed with the SEC prior to the
date of this prospectus.
We
incorporate by reference the following documents listed below (excluding any document or portion thereof to the extent such disclosure
is furnished and not filed):
|
· |
Our Annual Report on Form 10-K for the fiscal year ended December 31, 2021 filed
with the SEC on April 18, 2022; |
|
|
|
|
· |
Our Quarterly Report on Form 10-Q for the fiscal quarter ended March 31, 2022 filed
with the SEC on May 23, 2022; |
|
|
|
|
· |
Our Current Reports on Form 8-K filed with the SEC on February 15, 2022, February
17, 2022, February 23, 2022, April 4, 2022, April 18, 2022, April 25, 2022, April 27, 2022, May 9, 2022, and June 9, 2022, June 23,
2022, July 13, 2022 and July 27, 2022; and |
|
|
|
|
· |
Our Preliminary Proxy Statement and Definitive Proxy Statement on Schedule 14A filed
with the SEC on and February 22, 2022 and March 4, 2022, respectively. |
Information
in several of the documents referred to above that are incorporated by reference in this prospectus was filed prior to the 1-for-150 reverse
split of our common stock that was effective on April 25, 2022 and does not reflect the effects of such reverse stock split.
This
prospectus forms part of a registration statement on Form S-1 that we filed with the SEC. This prospectus does not contain all of the
information set forth in the registration statement and the exhibits to the registration statement or the documents incorporated by reference
herein and therein. For further information with respect to us and the securities that we are offering under this prospectus, we refer
you to the registration statement and the exhibits and schedules filed as a part of the registration statement and the documents incorporated
by reference herein and therein. You should rely only on the information incorporated by reference or provided in this prospectus and
registration statement. We have not authorized anyone else to provide you with different information. You should not assume that the
information in this prospectus and the documents incorporated by reference herein and therein is accurate as of any date other than the
respective dates thereof.
All
reports and other documents we subsequently file pursuant to Section 13(a), 13(c), 14 or 15(d) of the Exchange Act prior to the
termination of this offering, including all such documents we may file with the SEC after the date of the initial registration statement
and prior to the effectiveness of the registration statement, but excluding any information furnished to, rather than filed with, the
SEC, will also be incorporated by reference into this prospectus and deemed to be part of this prospectus from the date of the filing
of such reports and documents.
Any
information in any of the foregoing documents will automatically be deemed to be modified or superseded to the extent that information
in this prospectus or in a later filed document that is incorporated or deemed to be incorporated herein by reference modifies or replaces
such information.
Upon
written or oral request, we will provide you without charge a copy of any or all of the documents that are incorporated by reference
into this prospectus including but limited to financial statement information and exhibits that are specifically incorporated by reference
into such documents. Requests should be directed to ToughBuilt Industries, Inc., Attention: Martin Galstyan, CFO, 8669 Research Drive,
Irvine, CA 92618, martin.g@toughbuilt.com or (949) 528-3100. You may access this information https://ir.toughbuilt.com/all-sec-filings.
Except for the specific incorporated documents listed above, no information available on or through our website shall be deemed to be
incorporated in this prospectus or the registration statement of which it forms a part.
The
SEC maintains an internet website that contains reports, proxy and information statements and other information regarding the issuers
that file electronically with the SEC, including the Company, and can be accessed free of charge on the SEC’s website, http://www.sec.gov.
ToughBuilt Industries,
Inc.
12,240,000 Shares of
Common Stock
PROSPECTUS
_________________, 2022
Part
II
INFORMATION
NOT REQUIRED IN PROSPECTUS
Item 13. Other Expenses
of Issuance and Distribution.
The
following table sets forth the expenses in connection with this registration statement. All of such expenses are estimates, other than
the filing fees payable to the Securities and Exchange Commission. The Company will bear all of the costs incurred in connection with
this registration statement.
| |
| Amount
to be paid | |
SEC registration fee | |
$ | 4,352 | |
Accounting fees and expenses | |
| 5,000 | * |
Legal fees and expenses | |
| 150,000 | * |
Miscellaneous | |
| 20,000 | * |
TOTAL | |
$ | 179,352 | * |
*Estimate
Item 14. Indemnification
of Directors and Officers.
The
Company’s Articles of Incorporation and Bylaws provide that, to the fullest extent permitted by the laws of the State of Nevada,
any officer or director of the Company, who was or is a party or is threatened to be made a party to any threatened, pending or completed
action, suit or proceeding, whether civil, criminal, administrative or investigative, by reason of the fact that he or she is or was
or has agreed to serve at the request of the Company as a director, officer, employee or agent of the Company, or while serving as a
director or officer of the Company, is or was serving or has agreed to serve at the request of the Company as a director, officer, employee
or agent (which, for purposes hereof, shall include a trustee, partner or manager or similar capacity) of another corporation, partnership,
joint venture, trust, employee benefit plan or other enterprise, or by reason of any action alleged to have been taken or omitted in
such capacity. For the avoidance of doubt, the foregoing indemnification obligation includes, without limitation, claims for monetary
damages against the Indemnitee to the fullest extent permitted under Section 78.7502 of the Nevada Revised Statutes as in existence on
the date hereof.
The
indemnification provided shall be from and against expenses (including attorneys’ fees), judgments, fines and amounts paid in settlement
actually and reasonably incurred by the indemnitee or on the indemnitee’s behalf in connection with such action, suit or proceeding
and any appeal therefrom, but shall only be provided if the indemnitee acted in good faith and in a manner the indemnitee reasonably
believed to be in or not opposed to the best interests of the Company, and, with respect to any criminal action, suit or proceeding,
had no reasonable cause to believe the indemnitee’s conduct was unlawful.
In
the case of any threatened, pending or completed action or suit by or in the right of the Company to procure a judgment in its favor
by reason of the fact that he or she is or was a director, officer, employee or agent of the Company, or while serving as a director
or officer of the Company, is or was serving or has agreed to serve at the request of the Company as a director, officer, employee or
agent of another corporation, partnership, joint venture, trust, employee benefit plan or other enterprise, no indemnification shall
be made in respect of any claim, issue or matter as to which the indemnitee shall have been adjudged to be liable to the Company unless,
and only to the extent that, the Nevada courts or the court in which such action or suit was brought shall determine upon application
that, despite the adjudication of liability but in view of all the circumstances of the case, the indemnitee is fairly and reasonably
entitled to indemnity for such expenses which the Nevada courts or such other court shall deem proper.
The
termination of any action, suit or proceeding by judgment, order, settlement, conviction, or upon a plea of nolo contendere or its equivalent,
shall not, of itself, create a presumption that he or she did not act in good faith and in a manner which Indemnitee reasonably believed
to be in or not opposed to the best interests of the Company, and, with respect to any criminal action or proceeding, had reasonable
cause to believe that the indemnitee’s conduct was unlawful.
To
the extent that indemnification for liabilities arising under the Securities Act may be permitted to directors, officers or persons controlling
our company pursuant to the foregoing provisions, we have been informed that, in the opinion of the SEC, such indemnification is against
public policy as expressed in the Securities Act and is therefore unenforceable. If a claim for indemnification against such liabilities
(other than the payment by us of expenses incurred or paid by a director, officer or controlling person of our company in the successful
defense of any action, suit or proceeding) is asserted by any of our directors, officers or controlling persons in connection with
the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question whether such indemnification by us is against public policy as expressed in
the Securities Act and will be governed by the final adjudication of that issue.
In
any placement agent agreement we enter into in connection with the sale of the securities being registered hereby, the Placement Agent
will agree to indemnify, under certain conditions, us, our directors, our officers and persons who control us within the meaning of the
Securities Act of 1933, as amended, or the Securities Act, against certain liabilities.
Item 15. Recent Sales
of Unregistered Securities.
Set
forth below is information regarding shares of capital stock issued by us within the past three years which were not registered under
the Securities Act.
Private Placement
On
July 27, 2022, we consummated the closing of a private placement (the “Private Placement”), pursuant to the terms and conditions
of the Securities Purchase Agreement, dated as of July 25, 2022 (the “Purchase Agreement”), by and among the Company and
certain purchasers named on the signature pages thereto (the “Purchasers”). At the closing of the Private Placement, the
Company issued (i) 700,000 shares of common stock (the “Placement Shares”), (ii) the pre-funded warrants (the “Prefunded
Warrants”) to purchase an aggregate of 3,300,000 shares of common stock; (iii) Series A Preferred Investment Options
to purchase an aggregate of 4,000,000 shares of common stock exercisable immediately until the third anniversary of such date for $5.00
per share, subject to adjustment; and (iv) Series B Preferred Investment Options to purchase an aggregate of 4,000,000 shares of
common stock exercisable immediately until the second anniversary of such date for $5.00 per share, subject to adjustment. The purchase
price of each Placement Share and associated Preferred Investment Option was $5.00 and the purchase price of each Prefunded Warrant and
associated Preferred Investment Option was $4.9999. H.C. Wainwright & Co., LLC (“Wainwright”) acted as the exclusive
placement agent for the Private Placement. As part of Wainwright’s compensation, we issued designees of Wainwright warrants (the
“Wainwright Warrants”) to purchase up to 240,000 shares of our common stock, which is equivalent to 6.0% of the Placement
Shares and Prefunded Warrants sold in the Private Placement for $6.25 per share until July 28, 2025.
The
Company issued the foregoing securities pursuant to the exemption from the registration requirements of the Securities Act, available
under Section 4(a)(2) and/or Rule 506(b) of Regulation D promulgated thereunder.
Issuance of Warrants
As
previously reported by the Company on a Current Report on Form 8-K filed with the SEC on February 17, 2022, on February 15, 2022, the
Company entered into the February Purchase Agreement with institutional investors named therein, pursuant to which the Company issued,
in a registered direct offering, an aggregate of $5,000,000 of Preferred Stock (split evenly among Series F Preferred Stock and Series
G Preferred Stock, the “Preferred Stock”). The shares of Preferred Stock have a stated value of $1,000 per share and are
convertible, following the date of the issuance thereof, into an aggregate of 83,334 shares of common stock of the Company upon the conversion
of Series F Preferred Stock and into an aggregate of 83,334 shares of common stock of the Company upon the conversion of Series G Preferred
Stock, at a conversion price of $30 per share each. Though the Preferred Stock and the underlying shares of common stock were offered
pursuant to the Second Form S-3, in a concurrent private placement, the Company also issued to such investors unregistered warrants (the
“February Warrants”) to purchase up to an aggregate of 125,000 shares of the Company’s common stock, at an exercise
price of $37.65 per share.
As
compensation to Wainwright, as the exclusive placement agent in connection with the offering issued to designees of Wainwright warrants
to purchase up to 10,000 shares of common stock (the “Wainwright February Warrants”). The Wainwright February Warrants are
exercisable for $37.50 until February 15, 2027.
The
Company issued the February Warrants and the Wainwright February Warrants pursuant to the exemption from the registration requirements
of the Securities Act, available under Section 4(a)(2) and/or Rule 506(b) of Regulation D promulgated thereunder.
Issuance of Series
E Non-Convertible Preferred Stock
As
previously reported by the Company on Forms 8-K filed with the SEC on November 23, 2020 and April 1, 2021, on November 20, 2020, pursuant
to an exchange agreement, dated November 20, 2022 (the “Exchange Agreement”), between the Company and an institutional investor
(the “Investor”), the Investor exchanged their Series A Senior Secured Convertible Note, Series B Senior Convertible Note,
and common stock purchase warrants originally purchased pursuant to a Securities Purchase Agreement, dated August 19, 2019 (the “Purchase
Agreement”). Pursuant to the Exchange Agreement, the Investor exchanged their securities and agreed to extinguish its first priority
lien on all of the assets of the Company for (i) a cash payment of $744,972; (ii) 12,334 shares of the Company’s common
stock; (iii) a warrant to purchase up to an aggregate of 3,834 shares of the common stock for $150 per share, subject to anti-dilution
protection, until August 19, 2024; and (iv) nine shares of Series E Non-Convertible Preferred Stock (the “Series E Preferred
Stock”) of the Company. On March 26, 2021, the Company issued nine shares of such Series E Preferred Stock to the Investor.
The Company issued foregoing shares of common stock, warrant and Series E Preferred Stock in reliance upon Section 3(a)(9) of the
Securities Act as involving an exchange by the Company exclusively with its security holders. In connection with the Company’s
February 2022 registered direct offering, on February 15, 2022, the warrant was amended to increase the number of shares of common stock
issuable upon the exercise of the warrant to 76,667 shares of common stock for $7.50 per share. In connection with the Company’s
public offering of units and prefunded units in June 2022, the warrant was terminated and the nine shares of Series E Preferred Stock
were redeemed and canceled.
Item 16. Exhibits
and Financial Statement Schedules.
(a) Exhibits:
Reference is made to the Exhibit Index following the signature pages hereto, which Exhibit Index is hereby incorporated into this Item.
(b) Financial
Statement Schedules: All schedules are omitted because the required information is inapplicable, or the information is presented
in the financial statements and the related notes.
Item 17. Undertakings.
The
undersigned registrant hereby undertakes:
1. To
file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:
(i) To
include any prospectus required by section 10(a)(3) of the Securities Act of 1933;
(ii) To
reflect in the prospectus any facts or events arising after the effective date of the registration statement (or the most recent post-effective
amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the registration
statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities
offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering
range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the
changes in volume and price represent no more than 20% change in the maximum aggregate offering price set forth in the “Calculation
of Registration Fee” table in the effective registration statement.
(iii) To
include any material information with respect to the plan of distribution not previously disclosed in the registration statement or any
material change to such information in the registration statement.
2. For
the purposes of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form
of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof.
3. To
remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination
of the offering.
4. For
the purpose of determining liability under the Securities Act of 1933 to any purchaser:
(i) If
the registrant is relying on Rule 430B:
(a) Each
prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration statement as of
the date the filed prospectus was deemed part of and included in the registration statement; and
(b) Each
prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration statement in reliance
on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing the
information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the
registration statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first
contract of sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of
the issuer and any person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration
statement relating to the securities in the registration statement to which that prospectus relates, and the offering of such securities
at that time shall be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration
statement or prospectus that is part of the registration statement or made in a document incorporated or deemed incorporated by reference
into the registration statement or prospectus that is part of the registration statement will, as to a purchaser with a time of contract
of sale prior to such effective date, supersede or modify any statement that was made in the registration statement or prospectus that
was part of the registration statement or made in any such document immediately prior to such effective date; or
(ii) If
the registrant is subject to Rule 430C, each prospectus filed pursuant to Rule 424(b) as part of a registration statement
relating to an offering, other than registration statements relying on Rule 430B or other than prospectuses filed in reliance on
Rule 430A, shall be deemed to be part of and included in the registration statement as of the date it is first used after effectiveness.
Provided, however, that no statement made in a registration statement or prospectus that is part of the registration statement or
made in a document incorporated or deemed incorporated by reference into the registration statement or prospectus that is part of the
registration statement will, as to a purchaser with a time of contract of sale prior to such first use, supersede or modify any statement
that was made in the registration statement or prospectus that was part of the registration statement or made in any such document immediately
prior to such date of first use.
5. For
the purposes of determining liability under the Securities Act of 1933 to any purchaser in the initial distributions of the
securities, the undersigned registrant undertakes that in a primary offering of securities of the undersigned registrant pursuant to
this registration statement, regardless of the underwriting method used to sell the securities to the purchaser, if the securities are
offered or sold to such purchaser by means of any of the following communications, the undersigned registrant will be a seller to the
purchaser and will be considered to offer or sell such securities to such purchaser:
(i) Any
preliminary prospectus or prospectus of the undersigned registrant relating to the offering required to be filed pursuant to Rule 424;
(ii) Any
free writing prospectus relating to the offering prepared by or on behalf of the undersigned registrant or used or referred to by the
undersigned registrant;
(iii) The
portion of any other free writing prospectus relating to the offering containing material information about the undersigned registrant
or its securities provided by or on behalf of the undersigned registrant; and
(iv) Any
other communication that is an offer in the offering made by the undersigned registrant to the purchaser.
6. The
undersigned registrant hereby undertakes to provide to the underwriter at the closing specified in the underwriting agreements certificates
in such denominations and registered in such names as required by the underwriter to permit prompt delivery to each purchaser.
7. The
undersigned registrant hereby undertakes that:
(i) For
purposes of determining any liability under the Securities Act of 1933, the information omitted from the form of prospectus
filed as part of this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant
pursuant to Rule 424(b) (1) or (4) or 497(h) under the Securities Act shall be deemed to be part of this registration
statement as of the time it was declared effective.
(ii) For
the purpose of determining any liability under the Securities Act of 1933, each post-effective amendment that contains a form
of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such
securities at that time shall be deemed to be the initial bona fide offering thereof.
Insofar
as indemnification for liabilities arising under the Securities Act may be permitted to our directors, officers and controlling persons
pursuant to the provisions above, or otherwise, we have been advised that in the opinion of the SEC such indemnification is against public
policy as expressed in the Securities Act, and is, therefore, unenforceable. In the event that a claim for indemnification against such
liabilities, other than the payment by us of expenses incurred or paid by one of our directors, officers, or controlling persons in the
successful defense of any action, suit or proceeding, is asserted by one of our directors, officers, or controlling persons in connection
with the securities being registered, we will, unless in the opinion of our counsel the matter has been settled by controlling precedent,
submit to a court of appropriate jurisdiction the question of whether such indemnification is against public policy as expressed in the
Securities Act, and we will be governed by the final adjudication of such issue.
EXHIBIT
INDEX
Exhibit
No.: |
|
Description
of Exhibit: |
|
Previously
Filed and Incorporated
by Reference herein: |
|
Date Filed: |
1.1 |
|
At
The Market Offering Agreement, dated December 7, 2020, between ToughBuilt Industries, Inc. and H.C. Wainwright & Co., LLC |
|
Exhibit
1.1 to Registration Statement on Form S-3 (File No. 333-251185) |
|
December
7, 2020 |
1.2 |
|
At
The Market Offering Agreement, dated February 1, 2021, between ToughBuilt Industries, Inc. and H.C. Wainwright & Co., LLC |
|
Exhibit
1.1 to Registration Statement on Form S-3 (File No: 333-252630) |
|
February
2, 2021 |
3.1 |
|
Articles
of Incorporation, dated April 9, 2012 |
|
Exhibit
3.1 to Registration Statement on Form S-1 |
|
July
9, 2018 |
3.1.2 |
|
Certificate
of Amendment, dated December 29, 2015 |
|
Exhibit
3.1 to Registration Statement on Form S-1 |
|
July
9, 2018 |
3.1.3 |
|
Certificate
of Change Pursuant to NRS 78.209, dated October 5, 2016 |
|
Exhibit
3.1 to Registration Statement on Form S-1 |
|
July
9, 2018 |
3.1.4 |
|
Certificate
of Change Pursuant to NRS 78.209, dated September 13, 2018 |
|
Exhibit
3.4 to Registration Statement on Form S-1/A |
|
September
19, 2018 |
3.1.5 |
|
Certificate
of Designations of Class B Convertible Preferred Stock, dated October 5, 2016 |
|
Exhibit
3.3 to Registration Statement on Form S-1 |
|
July
9, 2018 |
3.1.6 |
|
Certificate
of Amendment to the Certificate of Incorporation, dated January 17, 2020 |
|
Exhibit
3.1 to Current Report on Form 8-K |
|
January
17, 2020 |
3.1.7 |
|
Certificate
of Designation of Series E Non-Convertible Preferred Stock dated as of March 26, 2021 |
|
Exhibit
3.1 to Current Report on Form 8-K |
|
April
1, 2021 |
3.1.8 |
|
Certificate
of Designations of Series F Convertible Preferred Stock dated as of February 15, 2022 |
|
Exhibit
3.1 to Current Report on Form 8-K |
|
February
17, 2022 |
3.1.9 |
|
Certificate
of Designations of Series G Convertible Preferred Stock dated as of February 15, 2022 |
|
Exhibit
3.2 to Current Report on Form 8-K |
|
February
17, 2022 |
3.1.10 |
|
Certificate
of Amendment to the Articles of Incorporated, dated as of April 22, 2022 |
|
Exhibit
3.1 to Current Report on Form 8-K |
|
April
22, 2022 |
3.2 |
|
Amended
and Restated Bylaws, dated July 6, 2016 |
|
Exhibit
3.2 to Registration Statement on Form S-1 |
|
July
9, 2018 |
4.1 |
|
Warrant,
dated November 20, 2020, issued by ToughBuilt Industries, Inc. to the Investor |
|
Exhibit
4.1 to Current Report on Form 8-K |
|
November
23, 2020 |
Exhibit
No.: |
|
Description
of Exhibit: |
|
Previously Filed and
Incorporated
by Reference herein: |
|
Date Filed: |
4.2 |
|
Form of Common
Warrant dated as of July 14, 2021, issued by ToughBuilt Industries, Inc. to certain purchasers |
|
Exhibit 4.1
to Current Report on Form 8-K |
|
July 14,
2021 |
4.3 |
|
Form of Placement
Agent Warrant dated as of July 14, 2021, issued by ToughBuilt Industries, Inc. to H.C. Wainwright & Co., LLC |
|
Exhibit 4.2
to Current Report on Form 8-K |
|
July 14,
2021 |
4.4 |
|
Form
of Common Warrant dated as of February 15, 2022, issued by ToughBuilt Industries, Inc. to certain purchasers |
|
Exhibit
4.1 to Current Report on Form 8-K |
|
February
17, 2022 |
4.5 |
|
Form
of Placement Agent Warrant dated as of February 15, 2022, issued by ToughBuilt Industries, Inc. to H.C. Wainwright & Co., LLC |
|
Exhibit
4.2 to Current Report on Form 8-K |
|
February
17, 2022 |
4.6 |
|
Form
of Warrant underlying Unit offered hereby |
|
Exhibit
4.6 to Registration Statement on Form S-1 |
|
May
13, 2022 |
4.7 |
|
Form
of pre-funded warrant underlying pre-funded unit offered hereby |
|
Exhibit
4.7 to Registration Statement on Form S-1 |
|
May
13, 2022 |
4.8 |
|
Form
of Placement Agent Warrant offered hereby |
|
Exhibit
4.8 to Registration Statement on Form S-1 |
|
May
13, 2022 |
4.9 |
|
Form
of Warrant |
|
Exhibit 4.1
to Form 8-K |
|
June
23, 2022 |
4.10 |
|
Form
of Prefunded Warrant |
|
Exhibit
4.2 to Form 8-K |
|
June
23, 2022 |
4.11 |
|
Form
of Placement Agent Warrant |
|
Exhibit
4.3 to Form 8-K |
|
June
23, 2022 |
4.12 |
|
Form
of Prefunded Common Stock Purchase Warrant |
|
Exhibit
4.1 to Form 8-K |
|
July
27, 2022 |
4.13 |
|
Form
of Series A Preferred Investment Option |
|
Form
4.2 to Form 8-K |
|
July
27, 2022 |
4.14 |
|
Form
of Series B Preferred Investment Option |
|
Form
4.3 to Form 8-K |
|
July
27, 2022 |
4.15 |
|
Form
of Placement Agent Preferred Investment Option |
|
Form
4.4 to Form 8-K |
|
July
27, 2022 |
5.1* |
|
Opinion of Carmel, Milazzo & Feil LLP |
|
|
|
|
10.1# |
|
Employment
Agreement dated as of January 3, 2017 by and between ToughBuilt Industries, Inc. and Michael Panosian |
|
Exhibit
10.3 to Registration Statement on Form S-1 |
|
July 9,
2018 |
10.2# |
|
Employment
Agreement dated as of January 3, 2017 by and between ToughBuilt Industries, Inc. and Zareh Khachatoorian |
|
Exhibit
10.4 to Registration Statement on Form S-1 |
|
July 9,
2018 |
10.3# |
|
Employment
Agreement dated as of January 3, 2017 by and between ToughBuilt Industries, Inc. and Josh Keeler |
|
Exhibit
10.6 to Registration Statement on Form S-1 |
|
July 9,
2018 |
10.4# |
|
Exchange
Agreement, dated November 20, 2020, between ToughBuilt Industries, Inc. and the Investor |
|
Exhibit
10.1 to Current Report on Form 8-K |
|
November
23, 2020 |
10.5 |
|
Form of
Securities Purchase Agreement dated as of July 11, 2021, by and between ToughBuilt Industries, Inc. and certain purchasers |
|
Exhibit
10.1 to Current Report on Form 8-K |
|
July 14,
2021 |
Exhibit
No.: |
|
Description of Exhibit: |
|
Previously Filed and Incorporated
by Reference herein: |
|
Date Filed: |
10.6 |
|
Form of Securities Purchase Agreement dated as of February 15, 2022, by and between ToughBuilt Industries, Inc. and certain purchasers |
|
Exhibit 10.1 to Current Report on Form 8-K |
|
February 17, 2022 |
10.7 |
|
Form of Letter Agreement dated as of February 18, 2022, between ToughBuilt Industries, Inc. and the purchasers pursuant to the Securities Purchase Agreement dated as of February 15, 2022 |
|
Exhibit 10.1 to Current Report on Form 8-K |
|
February 23, 2022 |
10.8 |
|
Form of Lock-up Agreement |
|
Exhibit 10.9 to Registration Statement on Form S-1 |
|
May 13, 2022 |
10.9 |
|
Warrant Repurchase Agreement, June 8, 2022, between ToughBuilt Industries, Inc. and Alto Opportunity Master Fund, Spc - Segregated Master Portfolio B |
|
Exhibit 10.1 to Current Report on Form 8-K |
|
June 9, 2022 |
10.10** |
|
Form of Securities Purchase Agreement, dated June 17, 2022 |
|
Exhibit 10.1 to Form 8-K |
|
June 22, 2022 |
10.11** |
|
Form of Securities Purchase Agreement, dated as of July 25, 2022, by and among the Company and the Purchasers. |
|
Exhibit 10.1 to Form 8-K |
|
July 27, 2022 |
10.12** |
|
Form of Registration Rights Agreement, dated as of July 25, 2022, by and among the Company and the Purchasers. |
|
Exhibit 10.2 to Form 8-K |
|
July 27, 2022 |
14.1 |
|
Code of Ethics |
|
Exhibit 14.1 to Registration Statement on Form S-1 |
|
July 9, 2018 |
21.1 |
|
List of Subsidiaries |
|
Exhibit 21.1 to Annual Report on Form 10-K |
|
April 18, 2022 |
23.1* |
|
Consent of Marcum LLP |
|
|
|
|
23.2* |
|
Consent of Carmel, Milazzo & Feil LLP (included in Exhibit 5.1) |
|
|
|
|
24.1* |
|
Power of Attorney (included on signature page) |
|
|
|
|
| # | Management
contract or compensatory plan. |
| ** | Schedules,
exhibits and similar attachments have been omitted pursuant to Item 601(a)(5) of Regulation
S-K. The Company hereby undertakes to furnish copies of such omitted materials supplementally
upon request by the U.S. Securities and Exchange Commission. |
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed
on its behalf by the undersigned, thereunto duly authorized, in the City of Irvine, State of California, on the 3rd day of
August 2022.
|
TOUGHBUILT INDUSTRIES, INC. |
|
|
|
/s/ Michael Panosian |
|
Michael Panosian |
|
President, Chief Executive Officer and Chairman of the
Board of Directors |
|
(Principal Executive Officer) |
POWER OF ATTORNEY
KNOW
ALL MEN BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Michael Panosian and Martin Galstyan
his/her true and lawful attorney-in-fact and agent with full power of substitution and re-substitution, for him/her and in his name,
place and stead, in any and all capacities to sign any or all amendments (including, without limitation, post-effective amendments) to
this Registration Statement, any related Registration Statement filed pursuant to Rule 462(b) under the Securities Act of 1933,
as amended, and any or all pre- or post-effective amendments thereto, and to file the same, with all exhibits thereto, and all other
documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorney-in-fact and agent, full power
and authority to do and perform each and every act and thing requisite and necessary to be done in and about the premises, as fully for
all intents and purposes as he or she might or could do in person, hereby ratifying and confirming that said attorney-in-fact and agent,
or any substitute or substitutes for him, may lawfully do or cause to be done by virtue hereof.
Pursuant
to the requirements of the Securities Act of 1933, this Registration Statement has been signed by the following persons in the capacities
and on the dates indicated.
Signature |
|
|
Title |
|
Date |
|
|
|
|
|
|
/s/ Michael Panosian |
|
|
President, Chief Executive
Officer and Chairman of the Board of Directors
(Principal Executive Officer) |
|
August 3, 2022 |
Michael Panosian |
|
|
|
|
|
|
|
|
|
|
|
/s/ Martin Galstyan |
|
|
Chief Financial Officer
(Principal Financial Officer and Principal
Accounting Officer) |
|
August 3, 2022 |
Martin Galstyan |
|
|
|
|
|
|
|
|
|
|
|
/s/ Robert Faught |
|
|
Director |
|
August 3, 2022 |
Robert Faught |
|
|
|
|
|
|
|
|
|
|
|
/s/ Linda Moossaian |
|
|
Director |
|
August 3, 2022 |
Linda Moossaian |
|
|
|
|
|
|
|
|
|
|
|
/s/ William Placke |
|
|
Director |
|
August 3, 2022 |
William Placke |
|
|
|
|
|
ToughBuilt Industries (NASDAQ:TBLT)
Historical Stock Chart
From Aug 2024 to Sep 2024
ToughBuilt Industries (NASDAQ:TBLT)
Historical Stock Chart
From Sep 2023 to Sep 2024